<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6BA86EA7-6CB4-47D0-8274-149CC1BF3A01"><gtr:id>6BA86EA7-6CB4-47D0-8274-149CC1BF3A01</gtr:id><gtr:name>Metabolon Inc</gtr:name><gtr:address><gtr:line1>PO Box 110407</gtr:line1><gtr:line2>Research Triangle Park</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3D983A9E-0CE3-4F65-8618-B77AFE5F7332"><gtr:id>3D983A9E-0CE3-4F65-8618-B77AFE5F7332</gtr:id><gtr:name>Ectopharma Ltd</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78778E97-5A2E-40A6-A88F-137A343A3530"><gtr:id>78778E97-5A2E-40A6-A88F-137A343A3530</gtr:id><gtr:name>University of Toronto</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A400BE25-0A67-4DC4-90E2-F3C57C400F4D"><gtr:id>A400BE25-0A67-4DC4-90E2-F3C57C400F4D</gtr:id><gtr:name>Technion Israel Institue of Technology</gtr:name><gtr:address><gtr:line1>Taub Building</gtr:line1><gtr:line2>Technion  Institute of Technology</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Israel</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5D55E165-233B-426B-B629-5FFC887C1004"><gtr:id>5D55E165-233B-426B-B629-5FFC887C1004</gtr:id><gtr:name>MRC Technology (MRCT)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E7DED056-AD8E-45C6-B181-735534B89D31"><gtr:id>E7DED056-AD8E-45C6-B181-735534B89D31</gtr:id><gtr:name>University of Nice Sophia Antipolis</gtr:name><gtr:address><gtr:line1>Universite de Nice-Sophia Antipolis</gtr:line1><gtr:line2>28 Avenue Valrose</gtr:line2><gtr:line3>BP 2135</gtr:line3><gtr:line4>Nice</gtr:line4><gtr:line5>Cedex 2</gtr:line5><gtr:postCode>06103</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>France</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/8218E276-85FA-4CD5-86AA-232A830B5037"><gtr:id>8218E276-85FA-4CD5-86AA-232A830B5037</gtr:id><gtr:name>University of Texas at San Antonio</gtr:name><gtr:address><gtr:line1>One UTSA Circle</gtr:line1><gtr:line4>San Antonio</gtr:line4><gtr:line5>TX 78249-1644</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1971DE66-86B6-45D7-8CE0-39600A6FCCD6"><gtr:id>1971DE66-86B6-45D7-8CE0-39600A6FCCD6</gtr:id><gtr:name>Goethe University of Frankfurt am Main</gtr:name><gtr:address><gtr:line1>Max von Laue Str. 7</gtr:line1><gtr:line4>Frankfurt-am-Main</gtr:line4><gtr:postCode>60438</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/06E00C8B-5239-4BA3-84A0-477D5A697019"><gtr:id>06E00C8B-5239-4BA3-84A0-477D5A697019</gtr:id><gtr:name>University of Naples</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/217E9DB3-B1A3-4AAF-9DF8-59ECFB238168"><gtr:id>217E9DB3-B1A3-4AAF-9DF8-59ECFB238168</gtr:id><gtr:name>Saint-Petersburg State University</gtr:name><gtr:address><gtr:line1>7  Universitetskaya nab</gtr:line1><gtr:postCode>199034</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4C02B63A-6450-44EE-B38C-5D2C0C38D1E8"><gtr:id>4C02B63A-6450-44EE-B38C-5D2C0C38D1E8</gtr:id><gtr:name>University of Rome II (Tor Vergata)</gtr:name><gtr:address><gtr:line1>via Columbia, 2</gtr:line1><gtr:line4>Roma</gtr:line4><gtr:line5>I-00133</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FAE32A25-51D3-49EF-998F-281B3A47C212"><gtr:id>FAE32A25-51D3-49EF-998F-281B3A47C212</gtr:id><gtr:name>Helmholtz Association of German Research Centres</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/37DE1B14-06DD-4E06-AAC5-56F5BBED7FFF"><gtr:id>37DE1B14-06DD-4E06-AAC5-56F5BBED7FFF</gtr:id><gtr:name>MRC Toxicology Unit</gtr:name><gtr:address><gtr:line1>Hodgkin Building</gtr:line1><gtr:line2>University of Leicester</gtr:line2><gtr:line3>PO Box 138,  Lancaster Road</gtr:line3><gtr:line4>Leicester</gtr:line4><gtr:postCode>LE1 9HN</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/37DE1B14-06DD-4E06-AAC5-56F5BBED7FFF"><gtr:id>37DE1B14-06DD-4E06-AAC5-56F5BBED7FFF</gtr:id><gtr:name>MRC Toxicology Unit</gtr:name><gtr:address><gtr:line1>Hodgkin Building</gtr:line1><gtr:line2>University of Leicester</gtr:line2><gtr:line3>PO Box 138,  Lancaster Road</gtr:line3><gtr:line4>Leicester</gtr:line4><gtr:postCode>LE1 9HN</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3D983A9E-0CE3-4F65-8618-B77AFE5F7332"><gtr:id>3D983A9E-0CE3-4F65-8618-B77AFE5F7332</gtr:id><gtr:name>Ectopharma Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A400BE25-0A67-4DC4-90E2-F3C57C400F4D"><gtr:id>A400BE25-0A67-4DC4-90E2-F3C57C400F4D</gtr:id><gtr:name>Technion Israel Institue of Technology</gtr:name><gtr:address><gtr:line1>Taub Building</gtr:line1><gtr:line2>Technion  Institute of Technology</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Israel</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8218E276-85FA-4CD5-86AA-232A830B5037"><gtr:id>8218E276-85FA-4CD5-86AA-232A830B5037</gtr:id><gtr:name>University of Texas at San Antonio</gtr:name><gtr:address><gtr:line1>One UTSA Circle</gtr:line1><gtr:line4>San Antonio</gtr:line4><gtr:line5>TX 78249-1644</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/217E9DB3-B1A3-4AAF-9DF8-59ECFB238168"><gtr:id>217E9DB3-B1A3-4AAF-9DF8-59ECFB238168</gtr:id><gtr:name>Saint-Petersburg State University</gtr:name><gtr:address><gtr:line1>7  Universitetskaya nab</gtr:line1><gtr:postCode>199034</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4C02B63A-6450-44EE-B38C-5D2C0C38D1E8"><gtr:id>4C02B63A-6450-44EE-B38C-5D2C0C38D1E8</gtr:id><gtr:name>University of Rome II (Tor Vergata)</gtr:name><gtr:address><gtr:line1>via Columbia, 2</gtr:line1><gtr:line4>Roma</gtr:line4><gtr:line5>I-00133</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FAE32A25-51D3-49EF-998F-281B3A47C212"><gtr:id>FAE32A25-51D3-49EF-998F-281B3A47C212</gtr:id><gtr:name>Helmholtz Association of German Research Centres</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6BA86EA7-6CB4-47D0-8274-149CC1BF3A01"><gtr:id>6BA86EA7-6CB4-47D0-8274-149CC1BF3A01</gtr:id><gtr:name>Metabolon Inc</gtr:name><gtr:address><gtr:line1>PO Box 110407</gtr:line1><gtr:line2>Research Triangle Park</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78778E97-5A2E-40A6-A88F-137A343A3530"><gtr:id>78778E97-5A2E-40A6-A88F-137A343A3530</gtr:id><gtr:name>University of Toronto</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5D55E165-233B-426B-B629-5FFC887C1004"><gtr:id>5D55E165-233B-426B-B629-5FFC887C1004</gtr:id><gtr:name>MRC Technology (MRCT)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E7DED056-AD8E-45C6-B181-735534B89D31"><gtr:id>E7DED056-AD8E-45C6-B181-735534B89D31</gtr:id><gtr:name>University of Nice Sophia Antipolis</gtr:name><gtr:address><gtr:line1>Universite de Nice-Sophia Antipolis</gtr:line1><gtr:line2>28 Avenue Valrose</gtr:line2><gtr:line3>BP 2135</gtr:line3><gtr:line4>Nice</gtr:line4><gtr:line5>Cedex 2</gtr:line5><gtr:postCode>06103</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>France</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1971DE66-86B6-45D7-8CE0-39600A6FCCD6"><gtr:id>1971DE66-86B6-45D7-8CE0-39600A6FCCD6</gtr:id><gtr:name>Goethe University of Frankfurt am Main</gtr:name><gtr:address><gtr:line1>Max von Laue Str. 7</gtr:line1><gtr:line4>Frankfurt-am-Main</gtr:line4><gtr:postCode>60438</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/06E00C8B-5239-4BA3-84A0-477D5A697019"><gtr:id>06E00C8B-5239-4BA3-84A0-477D5A697019</gtr:id><gtr:name>University of Naples</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/A2F4FAAE-FB8D-4FDD-9C57-7AC79177EAEA"><gtr:id>A2F4FAAE-FB8D-4FDD-9C57-7AC79177EAEA</gtr:id><gtr:firstName>Gerry</gtr:firstName><gtr:surname>Melino</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U132670600"><gtr:id>C249DE5D-6667-43E4-872A-7D06A2EF15C6</gtr:id><gtr:title>The role of p53/p73 family members in the cytotoxic response.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U132670600</gtr:grantReference><gtr:abstractText>Many of the drugs used in cancer therapy, exert their action through the activation of the p53-family members. Indeed, loss of p53 function in cancer is associated with poor prognosis and resistance to chemotherapy. Moreover, this family of transcription factors play a key role in development of central nervous system, epidermal tissue and in overall organism metabolism. Using genetically modified mouse model and high throughput analysis, we aim to understand:
1) How these transcription factors mediate chemo sensitivity,
2) How they regulate organismal development and physiology.</gtr:abstractText><gtr:technicalSummary>The scope of the Apoptosis &amp;amp; Cancer Laboratory is to understand the fundamental mechanisms of cell death (apoptosis) and tissue response to injury caused by drugs, chemicals and endogenous molecules, like free radicals. In particular, we study the physiological functions of the p53 family proteins (namely p53, p63 and p73) and their involvement in tumorigenesis and neurodegeneration triggered by toxic insults. We make use of multiple scientific approaches ranging from systems biology (proteomic and genomic screenings) to the generation and characterization of genetically modified mouse models. 
We are also interested to the development of chemical compounds that can regulate expression and function of these transcription factors, and that could therefore have potential therapeutic applications. 

Objectives
Alterations of proteins that control cell proliferation, cell survival and cell death are the main causes of diseases such as cancer and neurodegenerative disorders and dictate the efficacy of drug treatment. The protein members of the p53 family, composed of TP63, TP73 and TP53 itself, are transcription factors that, by binding to the DNA, modulate the expression of multiple genes that play pivotal functions in the regulation of proliferation, differentiation, cell death, stem cell renewal and cell fate commitment. While p53 has been extensively studied over the last 32 years, p73 biology is still lagging behind despite lying at the crossroads between differentiation, cell cycle control and cell death. 

We aim to understand the mechanisms of p73 regulation during toxic insults and to define how it influences the outcome and severity of cellular and organism response to toxic insults. To this end, we are investigating several aspect of the p53-family biology, including:

1- p73 function in DNA damage response and cancer therapy, 
2- Characterization of in vivo DNA damage models &amp;amp; large-scale transcriptional analysis, 
3- p73, metabolism and ageing, 
4- Neuronal implications of p73 deficiency, 
5-Bioinformatic Evaluation of predictive value of p53 family in cancer progression and chemosensitivity in collaboration with Alexej Antonov (MRC Toxicology Unit),
6- MicroRNA and the p53 family in cancer progression in collaboration with Martin Bushell (MRC Toxicology Unit),
7- The deregulation of translation, in collaboration with Anne E. Willis (MRC Toxicology Unit),
8- Function and Pharmacological inhibition of the p73 E3 ubiquitin ligase ITCH.</gtr:technicalSummary><gtr:fund><gtr:end>2018-02-28</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2002-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>10580408</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Rome Tor Vergata</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>p73 degradation and microRNA</gtr:description><gtr:id>934453EB-3E22-4B65-A7AD-53546186F0CC</gtr:id><gtr:impact>Exchange of reagents, cooperation on experiments, exchange of personnel, production of joint scientific publications</gtr:impact><gtr:outcomeId>B15495AF467-1</gtr:outcomeId><gtr:partnerContribution>Allowed the collaboration on two areas: (i) p73 degradation, (ii) miR related to p73Analysis of the miR profile from invitro and in vivo samples to evaluate the fine regulation of p73 and p63 pathwaysAnalysis of murine ES cell committment and the p73 pathwaypreparation of the miR-34a (as a target of p73) knockout and its characterization</gtr:partnerContribution><gtr:piContribution>Characterization of novel pathway of degradation of p73, independent of ITCH. Characterization of the miR regulating p73 function.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Helmholtz Association of German Research Centres</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>German Center for Neurodegenerative Diseases (DZNE)</gtr:department><gtr:description>p73 degradation and microRNA</gtr:description><gtr:id>1F361CCC-C537-4301-93B4-58FBCE7A748B</gtr:id><gtr:impact>Exchange of reagents, cooperation on experiments, exchange of personnel, production of joint scientific publications</gtr:impact><gtr:outcomeId>B15495AF467-4</gtr:outcomeId><gtr:partnerContribution>Allowed the collaboration on two areas: (i) p73 degradation, (ii) miR related to p73Analysis of the miR profile from invitro and in vivo samples to evaluate the fine regulation of p73 and p63 pathwaysAnalysis of murine ES cell committment and the p73 pathwaypreparation of the miR-34a (as a target of p73) knockout and its characterization</gtr:partnerContribution><gtr:piContribution>Characterization of novel pathway of degradation of p73, independent of ITCH. Characterization of the miR regulating p73 function.</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>MRC Technology (MRCT)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRCT Centre for Therapeutics Discovery (CTD)</gtr:department><gtr:description>E3 Ubiquitin Inhibitors</gtr:description><gtr:id>8D4DD22E-AD0F-4747-AE65-31336CBDF769</gtr:id><gtr:impact>Development of in hibitors of the E3 ubiquitin ligase ITCH for cancer therapy. The work alloes a collaboration with top scientists (Chemistry Nobel Laureate) to validate the inhibitors. A further collaboration has been established with high profile, structural biology at the University of Frankfurt, to characterise the inhibitor/ITCH structure.</gtr:impact><gtr:outcomeId>1A1C404FA0E-1</gtr:outcomeId><gtr:partnerContribution>Performed Highthrouput screening for ITCH inhibitors Validated positive hits. Confirmed inhibitors</gtr:partnerContribution><gtr:piContribution>Set up robotized test for HTS. Validated targets found. Confirmed specificity of inhibitors.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Technion - Israel Institute of Technology</gtr:collaboratingOrganisation><gtr:country>Israel, State of</gtr:country><gtr:department>Department of Biochemistry</gtr:department><gtr:description>Itch Inhibitors Screening</gtr:description><gtr:id>FE5DF928-398A-4B86-A421-38469EEF69C8</gtr:id><gtr:impact>Development of High Throughput Screening for the E3 ubiquitin ligase ITCH and other members of the same HECT family. Currently the validation of the lead compounds is in progress.</gtr:impact><gtr:outcomeId>9D0F4E009D9-1</gtr:outcomeId><gtr:partnerContribution>Develop biochemical techniques to evaluate the activity and specificity of the inhibitors identified by MRC-T collaboration against ITCH.Evaluation of the efficacy of ITCH inhibitors in vitro on cancer cell linesResolution of the crystal structure of ITCH, and of the ITCH+inhibitor</gtr:partnerContribution><gtr:piContribution>Discussion on Methods and protocols.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Texas</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>M. D. Anderson Cancer Center</gtr:department><gtr:description>p73 degradation and microRNA</gtr:description><gtr:id>B2AFE56D-E0FB-477F-B1DC-B55309A700C7</gtr:id><gtr:impact>Exchange of reagents, cooperation on experiments, exchange of personnel, production of joint scientific publications</gtr:impact><gtr:outcomeId>B15495AF467-2</gtr:outcomeId><gtr:partnerContribution>Allowed the collaboration on two areas: (i) p73 degradation, (ii) miR related to p73Analysis of the miR profile from invitro and in vivo samples to evaluate the fine regulation of p73 and p63 pathwaysAnalysis of murine ES cell committment and the p73 pathwaypreparation of the miR-34a (as a target of p73) knockout and its characterization</gtr:partnerContribution><gtr:piContribution>Characterization of novel pathway of degradation of p73, independent of ITCH. Characterization of the miR regulating p73 function.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Goethe University Frankfurt</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Structural Biology Research Area</gtr:department><gtr:description>Itch Inhibitors Screening</gtr:description><gtr:id>82378F1B-135B-45FA-8109-F6B2810B7A46</gtr:id><gtr:impact>Development of High Throughput Screening for the E3 ubiquitin ligase ITCH and other members of the same HECT family. Currently the validation of the lead compounds is in progress.</gtr:impact><gtr:outcomeId>9D0F4E009D9-3</gtr:outcomeId><gtr:partnerContribution>Develop biochemical techniques to evaluate the activity and specificity of the inhibitors identified by MRC-T collaboration against ITCH.Evaluation of the efficacy of ITCH inhibitors in vitro on cancer cell linesResolution of the crystal structure of ITCH, and of the ITCH+inhibitor</gtr:partnerContribution><gtr:piContribution>Discussion on Methods and protocols.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Naples</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:department>Biochemistry Department</gtr:department><gtr:description>Itch Inhibitors Screening</gtr:description><gtr:id>5BF969F4-9744-4AB9-A889-BB17E0730ECF</gtr:id><gtr:impact>Development of High Throughput Screening for the E3 ubiquitin ligase ITCH and other members of the same HECT family. Currently the validation of the lead compounds is in progress.</gtr:impact><gtr:outcomeId>9D0F4E009D9-2</gtr:outcomeId><gtr:partnerContribution>Develop biochemical techniques to evaluate the activity and specificity of the inhibitors identified by MRC-T collaboration against ITCH.Evaluation of the efficacy of ITCH inhibitors in vitro on cancer cell linesResolution of the crystal structure of ITCH, and of the ITCH+inhibitor</gtr:partnerContribution><gtr:piContribution>Discussion on Methods and protocols.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Metabolon Inc</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Research and Development Metabolon</gtr:department><gtr:description>p53 family transcription</gtr:description><gtr:id>158C0EAB-75ED-42A2-A74F-F73240AE0A69</gtr:id><gtr:impact>Scientific Publications. Genes regulating metabolism. Toxic insults affecting metabolism via p53 family.</gtr:impact><gtr:outcomeId>eLFmPi7SvCJ-2</gtr:outcomeId><gtr:partnerContribution>DNA array profiling, ChIP analysis, Gene promoter studies.Metabolite identification by Mass Spectrometry.Transcription analysis by ChIP, array.
Metabolic profiling by Mass Spectrometry.</gtr:partnerContribution><gtr:piContribution>Identify target genes of the transcription factors p53/p63/p73, relevant in Cancer and Neurodegeneration. Involve DNA microarray, ChIP, luc-assay, trasncritional regulation. Experiments are both in vitro and in vivo. Specific interest is for genes regulating Metabolism, which is evaluated by Mass Spectorometric metabolomics.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Toronto</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:description>DNp73 knockout mice</gtr:description><gtr:id>71AA4EBF-24F4-4E87-A59B-6B71CEDE6BB2</gtr:id><gtr:impact>Production of joint scientific publications. Understanding of the molecuar mechanisms in Cancer and toxicity.</gtr:impact><gtr:outcomeId>14EF191D388-1</gtr:outcomeId><gtr:partnerContribution>Development, production and characterization of DNp73 mice to evaluate the role of this gene in DNA damage response.</gtr:partnerContribution><gtr:piContribution>Univ Toronto in close collaboration with our MRC group has developped, charaterized and stidied the KO mice of the gene DNp73, involved in DNA damage response.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Toronto</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:description>TAp73 knockout mice</gtr:description><gtr:id>1A43B034-1813-4CE4-851A-0A40ABEB474C</gtr:id><gtr:impact>Information on the molecular mechanisms of DNA damage repair systems. Production of joint scientific publications</gtr:impact><gtr:outcomeId>FD3B6F7253E-1</gtr:outcomeId><gtr:partnerContribution>Toronto, jointly produced KO mice for TAp73 gene, involved in DNA damage response.</gtr:partnerContribution><gtr:piContribution>Preparation of construct, Homologous recombination in ES cells. Developemt of the KO mice. Characterization of the phenotype</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Ectopharma Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Itch silencing</gtr:description><gtr:id>BC1790D6-E00B-42A1-8FCA-60CEB0D085F1</gtr:id><gtr:impact>Development and validation of shRNA silencing against the E3 ubiquitin ligase ITCH for therapy of p73-dependent tumours.</gtr:impact><gtr:outcomeId>8B5EF80B7EE-1</gtr:outcomeId><gtr:partnerContribution>Validation of ITCH inhibition as therapeutic target in cancer cells. Validation was performed both in vitro and in vivo.</gtr:partnerContribution><gtr:piContribution>Material Transfer Agreement - oncology application of Itch silencing in cancer</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Nice Sophia-Antipolis</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>Cell Biology</gtr:department><gtr:description>p73 degradation and microRNA</gtr:description><gtr:id>DDB6059E-3BA9-4D8F-B6D7-3EFC8EC19D40</gtr:id><gtr:impact>Exchange of reagents, cooperation on experiments, exchange of personnel, production of joint scientific publications</gtr:impact><gtr:outcomeId>B15495AF467-3</gtr:outcomeId><gtr:partnerContribution>Allowed the collaboration on two areas: (i) p73 degradation, (ii) miR related to p73Analysis of the miR profile from invitro and in vivo samples to evaluate the fine regulation of p73 and p63 pathwaysAnalysis of murine ES cell committment and the p73 pathwaypreparation of the miR-34a (as a target of p73) knockout and its characterization</gtr:partnerContribution><gtr:piContribution>Characterization of novel pathway of degradation of p73, independent of ITCH. Characterization of the miR regulating p73 function.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Saint Petersburg State University</gtr:collaboratingOrganisation><gtr:country>Russian Federation</gtr:country><gtr:description>p53 family transcription</gtr:description><gtr:id>E0342BC2-E7AB-4C4B-A6B5-F06388B232C7</gtr:id><gtr:impact>Scientific Publications. Genes regulating metabolism. Toxic insults affecting metabolism via p53 family.</gtr:impact><gtr:outcomeId>eLFmPi7SvCJ-1</gtr:outcomeId><gtr:partnerContribution>DNA array profiling, ChIP analysis, Gene promoter studies.Metabolite identification by Mass Spectrometry.Transcription analysis by ChIP, array.
Metabolic profiling by Mass Spectrometry.</gtr:partnerContribution><gtr:piContribution>Identify target genes of the transcription factors p53/p63/p73, relevant in Cancer and Neurodegeneration. Involve DNA microarray, ChIP, luc-assay, trasncritional regulation. Experiments are both in vitro and in vivo. Specific interest is for genes regulating Metabolism, which is evaluated by Mass Spectorometric metabolomics.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Rome Tor Vergata</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:department>Department of Experimental Medicine and Surgery</gtr:department><gtr:description>p53 family transcription</gtr:description><gtr:id>07841164-50F4-4427-A235-8C9253056E10</gtr:id><gtr:impact>Scientific Publications. Genes regulating metabolism. Toxic insults affecting metabolism via p53 family.</gtr:impact><gtr:outcomeId>eLFmPi7SvCJ-3</gtr:outcomeId><gtr:partnerContribution>DNA array profiling, ChIP analysis, Gene promoter studies.Metabolite identification by Mass Spectrometry.Transcription analysis by ChIP, array.
Metabolic profiling by Mass Spectrometry.</gtr:partnerContribution><gtr:piContribution>Identify target genes of the transcription factors p53/p63/p73, relevant in Cancer and Neurodegeneration. Involve DNA microarray, ChIP, luc-assay, trasncritional regulation. Experiments are both in vitro and in vivo. Specific interest is for genes regulating Metabolism, which is evaluated by Mass Spectorometric metabolomics.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Mini-Workshop on &quot;Science Integrity&quot;</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>85AE4E2B-C090-43BD-A229-C195E521730D</gtr:id><gtr:impact>Organisation of Mini-workshop focusing Science Integrity including talks and debate with scientists, journal editors and publishers.</gtr:impact><gtr:outcomeId>58caa17f4dfae4.33222517</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>FEBS Publication Committee, Budapest</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>9FD99297-EDBA-478D-A180-21D1EB82327C</gtr:id><gtr:impact>FEBS Publications Committee oversees the operation and development of FEBS' journals.</gtr:impact><gtr:outcomeId>5460935d635a40.58123425</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cell Processes: Life and death decisions&quot;. Biochemical Journal Symposium. Tsinghua University, Beijing. China</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0BCBD739-BD0C-404A-A4B8-809D64EE1081</gtr:id><gtr:impact>The talk was very well attended and provoked several questions

The talk provoked several interesting questions</gtr:impact><gtr:outcomeId>545fb066e72563.46185302</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>Identification of the mechanism of degradation of p73 by the ubiquitin E&amp;pound; ligase ITCH</gtr:description><gtr:grantRef>MC_U132670600</gtr:grantRef><gtr:id>C2F45790-C8F9-4CC5-BC70-630FD77233B1</gtr:id><gtr:impact>This patent identifies Itch, an ubiquitin ligase, as a novel regulator of the p53 family of tumour suppressors. The claims cover screens to identify modulators of Itch and use of Itch modulators as treatments for cancer. National phase</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>88575716444</gtr:outcomeId><gtr:patentId>US2009306187</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Itch-p73 Interaction</gtr:title><gtr:yearProtectionGranted>2009</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>The kinase c-Abl phosphorilated p73/p63 to regulate their function. In oocytes, p63 phosphorylation is crucial for their survival during chemotherapy. Gleevec (c-Abl inhibitor) protects from infertility following chemotherapy.</gtr:description><gtr:grantRef>MC_U132670600</gtr:grantRef><gtr:id>3C11569F-656E-426C-85AA-63BB95E57404</gtr:id><gtr:impact>This application relates to identification of the human sequence of Delta Np73 (including the promoter region) and manipulation of Delta Np73 expression/activity for treatment and diagnostics of cancer Patent filed by and managed by Eirex Therapeutics as a result of collaboration</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>42D15D89255</gtr:outcomeId><gtr:protection>Protection not required</gtr:protection><gtr:title>DNp73 &amp;amp; p63 phosphorylation by c-Abl</gtr:title><gtr:yearProtectionGranted>2009</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Science Foundation of Ireland</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>9CA493E4-7C1D-49D5-8C0A-6FFBC3FF089B</gtr:id><gtr:impact>Scientific advisor</gtr:impact><gtr:outcomeId>GUDykCWbaQc</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>University of Saint Petersburg, Russia</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>73043B01-A3EB-478E-B770-A9A25FC12F33</gtr:id><gtr:impact>Supervise the development and organisation of the scientific laboratory in University Saint Petersburg in Russia. Sponsored by the Ministry of Education and Science of the Russian Federation.</gtr:impact><gtr:outcomeId>ej6m1UNJP3M</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Consiglio Nazionale Ricerche (Italian Research Council)-Advisor</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>53283BFB-B0FD-4FBF-98C7-1428D36A8B54</gtr:id><gtr:impact>Scientific advisor to the Headoffice</gtr:impact><gtr:outcomeId>s7Q4Ggo3c15</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>European Brain Research Institute (Rome, Italy)</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>FFEB2B37-B6BD-4412-969E-DC43CC82E4C5</gtr:id><gtr:impact>Scientific Advisor</gtr:impact><gtr:outcomeId>PkXCbJrSSNp</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>VIB, biotech Research Institute of the Belgium Government</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>A4306EDC-96C3-4DE5-B455-1A0EB175E440</gtr:id><gtr:impact>Scientific Advisor to the VIB in Ghent, Belgium</gtr:impact><gtr:outcomeId>d6WHVzkTNah</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Gene disruption of TAp73.</gtr:description><gtr:id>3821A2EB-D4F0-4ABC-8D62-3AEB941DAC7D</gtr:id><gtr:impact>Transgenic mice prepared in collaboration with Tak W. Mak (Toronto). Models of cancer development following DNA damage in mice.</gtr:impact><gtr:outcomeId>2E51249CC72</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>TAp73 knockout mice</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>New knockout mice deleting DNp73 protein.</gtr:description><gtr:id>3B12B7A3-E333-46B0-A4A8-B228980FE702</gtr:id><gtr:impact>KO prepared in collaboration with Tak W. Mak (Toronto). Models of cancer development following DNA damage in mice.</gtr:impact><gtr:outcomeId>19A18F29D75</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>DNp73 knockout mice</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Tet-on inducible TAp73, DNp73, TAp63, DNp63 SAOS cell lines.</gtr:description><gtr:id>5E986FFF-A393-4A04-81C4-37C0931F542B</gtr:id><gtr:impact>Our in vitro models are currently used by dozen of laboratories in EU and USA</gtr:impact><gtr:outcomeId>B31A051E46A</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>p73 &amp; p63 inducible cell lines</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>knockout mice for SAM-domain containing isoforms of p63</gtr:description><gtr:id>8A402846-2114-4CA4-A2A8-44396274463F</gtr:id><gtr:impact>Model for cancer studies</gtr:impact><gtr:outcomeId>56ddadbf8a3394.81074961</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Trp63D13 Knockout mice</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Knockout mice for SAM-domain containing isoforms of p73</gtr:description><gtr:id>329A63A2-D5E2-4676-A5E6-0FC1682CD813</gtr:id><gtr:impact>Model for cancer studies</gtr:impact><gtr:outcomeId>56ddad5eb59c56.08914919</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Trp73D13 knockout mice</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Gene disruption of the deubiquitinase USP47</gtr:description><gtr:id>BD3662CA-DFFF-48B3-9D21-879CE59BA574</gtr:id><gtr:impact>Substrate of b-Trcp. Potential model of cancer in mice.</gtr:impact><gtr:outcomeId>DB9DD5B2BF5</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>USP47 knockout mice</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Generation of a series of Ab specific for different isoforms of p73, both in mouse and man.</gtr:description><gtr:id>A6312615-F0B2-4428-90FC-537BE2808084</gtr:id><gtr:impact>Useful reagents, not available commercially, to study p73 in development and cancer.</gtr:impact><gtr:outcomeId>72E859B777D</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Antibody for p73</gtr:title><gtr:type>Antibody</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Genetic deletion of ZNF750 gene (conditional knockout mouse)</gtr:description><gtr:id>D958367D-840E-4BBF-BCF5-695DE49BA680</gtr:id><gtr:impact>Potentially useful for cancer and skin development studies</gtr:impact><gtr:outcomeId>56ddac69bfcd18.50411845</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>ZNF750 knockout mice</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Production of knockout mice for FLASH, a protein component of the Cajal body in the cell nucleous, regulating cell cycle progression.</gtr:description><gtr:id>2975E389-0ECC-4EB0-8A33-49F55858BB1C</gtr:id><gtr:impact>Understanding the progression in cell cycle and the histone regulation</gtr:impact><gtr:outcomeId>kFzGssjZeSa</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>FLASH Knockout mice</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>07CFAA1E-5125-4241-9500-6597D81CE289</gtr:id><gtr:title>miRNAs, 'stemness' and skin.</gtr:title><gtr:parentPublicationTitle>Trends in biochemical sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/790609957cc0e09f1a717e3642256e60"><gtr:id>790609957cc0e09f1a717e3642256e60</gtr:id><gtr:otherNames>Aberdam D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0968-0004</gtr:issn><gtr:outcomeId>ADFD2A39406</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57A0FF3E-0727-4C66-9337-10B77A251B92</gtr:id><gtr:title>Functional characterization of a novel TP63 mutation in a family with overlapping features of Rapp-Hodgkin/AEC/ADULT syndromes.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part A</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/281c2778186d1bc2275bcd82b3e597cc"><gtr:id>281c2778186d1bc2275bcd82b3e597cc</gtr:id><gtr:otherNames>Serra V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1552-4825</gtr:issn><gtr:outcomeId>ds9zeBshhVj</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1890D624-8EA9-43EB-8149-4FA03FE52BC9</gtr:id><gtr:title>DNA methylation silences miR-132 in prostate cancer.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/09c0f58673cbe7af98774f2addbf8e73"><gtr:id>09c0f58673cbe7af98774f2addbf8e73</gtr:id><gtr:otherNames>Formosa A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>pm_12587_27_22310291</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>042ACCD3-2BA3-48CB-988F-5595F9E715D0</gtr:id><gtr:title>Identification of NCF2/p67phox as a novel p53 target gene.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1c7308741662db0613514a48b97b546b"><gtr:id>1c7308741662db0613514a48b97b546b</gtr:id><gtr:otherNames>Italiano D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>pm_12587_27_23187810</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E17836CC-69C9-47AD-91D2-319F2E3C1289</gtr:id><gtr:title>The sterile alpha-motif (SAM) domain of p63 binds in vitro monoasialoganglioside (GM1) micelles.</gtr:title><gtr:parentPublicationTitle>Biochemical pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/477204f369fe0a06770518a6ca315440"><gtr:id>477204f369fe0a06770518a6ca315440</gtr:id><gtr:otherNames>Rufini S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-2952</gtr:issn><gtr:outcomeId>fTW3fDuJdiV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CCE1716B-B221-464C-9F11-C73E4EA34B4E</gtr:id><gtr:title>P73 regulates cisplatin-induced apoptosis in ovarian cancer cells via a calcium/calpain-dependent mechanism.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9ff4715b50ebb25c967a09f4ed9498f9"><gtr:id>9ff4715b50ebb25c967a09f4ed9498f9</gtr:id><gtr:otherNames>Al-Bahlani S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>djUBSMWrMkb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4442F851-5059-479E-9169-25097045A96A</gtr:id><gtr:title>Structural Evolution and Dynamics of the p53 Proteins.</gtr:title><gtr:parentPublicationTitle>Cold Spring Harbor perspectives in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c2d32ba481cac8c9d4b86952cd56b122"><gtr:id>c2d32ba481cac8c9d4b86952cd56b122</gtr:id><gtr:otherNames>Chillemi G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2157-1422</gtr:issn><gtr:outcomeId>58c6ce013d1fc9.86909110</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9FEE9D43-1538-4D1F-8A07-66E8CBA7A909</gtr:id><gtr:title>p63 Sustains self-renewal of mammary cancer stem cells through regulation of Sonic Hedgehog signaling.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4a5b9121171963ceb0da2a53804cfcd"><gtr:id>a4a5b9121171963ceb0da2a53804cfcd</gtr:id><gtr:otherNames>Memmi EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>56cb40e7c37df1.38230671</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8EC07461-4FCE-4EE9-BB4A-4A1F35BE8E85</gtr:id><gtr:title>Itch gene polymorphisms in healthy population and in patients affected by rheumatoid arthritis and atopic dermatitis.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b13ac2d9bb05d386a9183ec426eae7fc"><gtr:id>b13ac2d9bb05d386a9183ec426eae7fc</gtr:id><gtr:otherNames>Bernardini S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>42BA06B4CF0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E4C8B66D-C28C-4F50-BC0F-2FA8AAC12961</gtr:id><gtr:title>FLASH is an essential component of Cajal bodies.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9a2cd7869fab1403870cb05824b98470"><gtr:id>9a2cd7869fab1403870cb05824b98470</gtr:id><gtr:otherNames>Barcaroli D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>F0BA601F931</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DE55A9EE-555C-4E96-BBF1-D54217146D12</gtr:id><gtr:title>Large scale integration of drug-target information reveals poly-pharmacological drug action mechanisms in tumor cell line growth inhibition assays.</gtr:title><gtr:parentPublicationTitle>Oncotarget</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bc92fafe95c6ea9d7e35409b3c85a70"><gtr:id>2bc92fafe95c6ea9d7e35409b3c85a70</gtr:id><gtr:otherNames>Knight RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1949-2553</gtr:issn><gtr:outcomeId>545fa6f29f07a1.88409443</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CC9ACDA4-9A3B-433C-8ADC-7383C22C1BA3</gtr:id><gtr:title>MicroRNA-191 triggers keratinocytes senescence by SATB1 and CDK6 downregulation.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8cb8d55f2ed73e9941c053cd7fb914e2"><gtr:id>8cb8d55f2ed73e9941c053cd7fb914e2</gtr:id><gtr:otherNames>Lena AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn><gtr:outcomeId>pm_12587_27_22683624</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A123C613-07DE-4809-A2A6-F5A4D4591E8C</gtr:id><gtr:title>Inactive and highly active, proteolytically processed transglutaminase-5 in epithelial cells.</gtr:title><gtr:parentPublicationTitle>The Journal of investigative dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b531ebeaa169fa2258037375aa0c51b"><gtr:id>9b531ebeaa169fa2258037375aa0c51b</gtr:id><gtr:otherNames>Pietroni V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-202X</gtr:issn><gtr:outcomeId>0CDC1403CC9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C5DCE319-F7B4-465C-9844-234CCB00B6C8</gtr:id><gtr:title>miR-7 and miR-214 are specifically expressed during neuroblastoma differentiation, cortical development and embryonic stem cells differentiation, and control neurite outgrowth in vitro.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/36e6bd83dfd373c441dfe6211f736a6c"><gtr:id>36e6bd83dfd373c441dfe6211f736a6c</gtr:id><gtr:otherNames>Chen H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn><gtr:outcomeId>k3Vkx1igQ7Q</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>041A59E9-2074-488B-9E5B-ECAC62B6F606</gtr:id><gtr:title>Tissue transglutaminase induction in the pressure-overloaded myocardium regulates matrix remodelling.</gtr:title><gtr:parentPublicationTitle>Cardiovascular research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2b2974384c9e4dccabf9ae97513a6b8c"><gtr:id>2b2974384c9e4dccabf9ae97513a6b8c</gtr:id><gtr:otherNames>Shinde AV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0008-6363</gtr:issn><gtr:outcomeId>5aaa670f358142.79007770</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A237AE82-36F9-4088-B7CF-E348506DF4CE</gtr:id><gtr:title>Exploration of individuality in drug metabolism by high-throughput metabolomics: The fast line for personalized medicine.</gtr:title><gtr:parentPublicationTitle>Drug discovery today</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1b7eadb288a944fc119be80e443a453"><gtr:id>e1b7eadb288a944fc119be80e443a453</gtr:id><gtr:otherNames>Trifonova O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1359-6446</gtr:issn><gtr:outcomeId>58c6d5ff55a582.98214295</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5627A043-C5B2-44C4-A97B-8D29BD2C1E7D</gtr:id><gtr:title>Transglutaminase 2 is involved in autophagosome maturation.</gtr:title><gtr:parentPublicationTitle>Autophagy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b68d4a44c2284d1967609344637ababf"><gtr:id>b68d4a44c2284d1967609344637ababf</gtr:id><gtr:otherNames>D'Eletto M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1554-8627</gtr:issn><gtr:outcomeId>5D22E0895D2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2EE63932-DA53-4656-87D4-F140D3CCBCE9</gtr:id><gtr:title>The E3 ubiquitin ligase WWP1 regulates ?Np63-dependent transcription through Lys63 linkages.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9e4119986f75688fbc0aed5020f48894"><gtr:id>9e4119986f75688fbc0aed5020f48894</gtr:id><gtr:otherNames>Peschiaroli A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn><gtr:outcomeId>kckY426KkTH</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E12E06D9-5609-42DA-9240-BE475FE6682C</gtr:id><gtr:title>MIRUMIR: an online tool to test microRNAs as biomarkers to predict survival in cancer using multiple clinical data sets.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3f94a8475d91b280288b93fb65ec109e"><gtr:id>3f94a8475d91b280288b93fb65ec109e</gtr:id><gtr:otherNames>Antonov AV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>pm_12587_27_23175189</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>621882DF-F7D1-4DF0-B488-463A1C9ABF9A</gtr:id><gtr:title>p63 supports aerobic respiration through hexokinase II.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e031c271351b66689cde41b23e8e02ba"><gtr:id>e031c271351b66689cde41b23e8e02ba</gtr:id><gtr:otherNames>Viticchi? G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>56cb40e4056471.35065463</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>59A79C77-FCCD-45D1-B6D2-765A0140BA5F</gtr:id><gtr:title>Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancer.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/11b8def079cf2505dd3d25563d4fcb61"><gtr:id>11b8def079cf2505dd3d25563d4fcb61</gtr:id><gtr:otherNames>Tucci P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_12587_27_22949650</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E8A92189-472D-4CB8-B90B-20143728C5A7</gtr:id><gtr:title>Recognition of p63 by the E3 ligase ITCH: Effect of an ectodermal dysplasia mutant.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ab7a486be5391b20fee16b0830ba8c78"><gtr:id>ab7a486be5391b20fee16b0830ba8c78</gtr:id><gtr:otherNames>Bellomaria A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>G2WxjJzv6br</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>577C4281-7C00-41E7-91EB-15E867599016</gtr:id><gtr:title>Ordering of caspases in cells undergoing apoptosis by the intrinsic pathway.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/75863d44d38390b793a438ac87b9f44b"><gtr:id>75863d44d38390b793a438ac87b9f44b</gtr:id><gtr:otherNames>Inoue S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>E672FD94793</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5087410C-08FA-40EF-8F18-A8B8B39EF910</gtr:id><gtr:title>Apoptin induces apoptosis by changing the equilibrium between the stability of TAp73 and ?Np73 isoforms through ubiquitin ligase PIR2.</gtr:title><gtr:parentPublicationTitle>Apoptosis : an international journal on programmed cell death</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/07eb229cb976cc02c728c238529f359d"><gtr:id>07eb229cb976cc02c728c238529f359d</gtr:id><gtr:otherNames>Taebunpakul P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1360-8185</gtr:issn><gtr:outcomeId>pm_12587_27_22484480</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1EE32C7-269F-4691-AFF5-BC1E90C0A032</gtr:id><gtr:title>Neuroblastoma: oncogenic mechanisms and therapeutic exploitation of necroptosis.</gtr:title><gtr:parentPublicationTitle>Cell death &amp; disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/370225cfc75977d43980762e8cd70a1a"><gtr:id>370225cfc75977d43980762e8cd70a1a</gtr:id><gtr:otherNames>Nicolai S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56cb40e03ae4f3.23842604</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6C905BCD-5526-4234-B6A2-63D8848C8F34</gtr:id><gtr:title>Resuscitating supplementary information: is the solution a two-for-one offer?</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bc92fafe95c6ea9d7e35409b3c85a70"><gtr:id>2bc92fafe95c6ea9d7e35409b3c85a70</gtr:id><gtr:otherNames>Knight RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>pm_12587_27_22231502</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C9171B5-E765-4847-93A8-FDB4517F5B90</gtr:id><gtr:title>p63, a story of mice and men.</gtr:title><gtr:parentPublicationTitle>The Journal of investigative dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf44087a5f31ba492430c31d77c41bc8"><gtr:id>bf44087a5f31ba492430c31d77c41bc8</gtr:id><gtr:otherNames>Vanbokhoven H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-202X</gtr:issn><gtr:outcomeId>ptvxAiFPAw2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7252DE4B-2238-4DF2-923A-6CB0CAC31F42</gtr:id><gtr:title>SynTarget: an online tool to test the synergetic effect of genes on survival outcome in cancer.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8202ec23ce7877b2a6c8080563ce1fe"><gtr:id>f8202ec23ce7877b2a6c8080563ce1fe</gtr:id><gtr:otherNames>Amelio I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>58c6ce0102fba6.78622115</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AD846B5C-4E0A-4069-878B-630B1F9230B8</gtr:id><gtr:title>Itch self-polyubiquitylation occurs through lysine-63 linkages.</gtr:title><gtr:parentPublicationTitle>Biochemical pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d19b6a16711153c55595cec761ab22ea"><gtr:id>d19b6a16711153c55595cec761ab22ea</gtr:id><gtr:otherNames>Scialpi F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-2952</gtr:issn><gtr:outcomeId>AC5806AA8E0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA60DB62-D32E-41E2-879A-228417A5FE14</gtr:id><gtr:title>Current genome editing tools in gene therapy: new approaches to treat cancer.</gtr:title><gtr:parentPublicationTitle>Current gene therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0ef7e668f4e701135bf911259b63c1fb"><gtr:id>0ef7e668f4e701135bf911259b63c1fb</gtr:id><gtr:otherNames>Shuvalov O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1566-5232</gtr:issn><gtr:outcomeId>56cb40e8e39949.77505384</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B183BFC2-F5E3-4EF1-A250-27DF3E0BBE6D</gtr:id><gtr:title>Interference with the p53 family network contributes to the gain of oncogenic function of mutant p53 in hepatocellular carcinoma.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7cfd72621f0d7c9131963eb2db7658cb"><gtr:id>7cfd72621f0d7c9131963eb2db7658cb</gtr:id><gtr:otherNames>Schilling T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn><gtr:outcomeId>oam7vVC7jLZ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D4091C10-82DF-499B-910D-901FDC25F56C</gtr:id><gtr:title>Human EHMT2/G9a activates p53 through methylation-independent mechanism.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8c49a7caeb76a910b5c41aac8f5e23c9"><gtr:id>8c49a7caeb76a910b5c41aac8f5e23c9</gtr:id><gtr:otherNames>Rada M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>58c6cdfd539cb2.64836694</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB60506A-FA52-404D-B1C5-52B9CFD92E04</gtr:id><gtr:title>Characterization of TG2 and TG1-TG2 double knock-out mouse epidermis.</gtr:title><gtr:parentPublicationTitle>Amino acids</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ac6030fe0ca899c4de3fb89496640b7"><gtr:id>3ac6030fe0ca899c4de3fb89496640b7</gtr:id><gtr:otherNames>Pitolli C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0939-4451</gtr:issn><gtr:outcomeId>58c6cdfd261229.23970390</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F80198AB-4DCB-45CE-92B2-9457A35AFAA0</gtr:id><gtr:title>Non-alcoholic fatty liver disease severity is modulated by transglutaminase type 2.</gtr:title><gtr:parentPublicationTitle>Cell death &amp; disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a77b6682fc0043a2f804f9abcaf533bd"><gtr:id>a77b6682fc0043a2f804f9abcaf533bd</gtr:id><gtr:otherNames>Piacentini M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:outcomeId>5aaa6663d21b29.76964375</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3FF1B6C5-065C-4481-BEFB-80056129E5E4</gtr:id><gtr:title>Tissue-specific expression of p73 C-terminal isoforms in mice.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf6dbcc7eab91ddd02d8dafa51460879"><gtr:id>bf6dbcc7eab91ddd02d8dafa51460879</gtr:id><gtr:otherNames>Grespi F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>pm_12587_27_23159862</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>40CDFF67-63C5-4963-8C8A-6EA59B235AE4</gtr:id><gtr:title>Transglutaminase 2 is needed for the formation of an efficient phagocyte portal in macrophages engulfing apoptotic cells.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4e7b31c2455bd03300cd43f1f2e5a29a"><gtr:id>4e7b31c2455bd03300cd43f1f2e5a29a</gtr:id><gtr:otherNames>T?th B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>BF3AA55CB97</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CC1DD937-E608-4826-A746-0C7F5ECF6F66</gtr:id><gtr:title>Parathyroid hormone-related protein confers chemoresistance by blocking apoptosis signaling via death receptors and mitochondria.</gtr:title><gtr:parentPublicationTitle>International journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e7c455b4513daed2188f929250825690"><gtr:id>e7c455b4513daed2188f929250825690</gtr:id><gtr:otherNames>Gagiannis S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0020-7136</gtr:issn><gtr:outcomeId>EA7D64354DF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>49720BDF-4AE1-41E3-95E0-11920E10AA35</gtr:id><gtr:title>Non-oncogenic roles of TAp73: from multiciliogenesis to metabolism.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1c63aee72b7437a5e5af24756498853"><gtr:id>e1c63aee72b7437a5e5af24756498853</gtr:id><gtr:otherNames>Nemajerova A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>5aaa6665b12a71.11271417</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C750D0F1-A106-4AF7-B11F-1195FD53A577</gtr:id><gtr:title>NMR structure of the p63 SAM domain and dynamical properties of G534V and T537P pathological mutants, identified in the AEC syndrome.</gtr:title><gtr:parentPublicationTitle>Cell biochemistry and biophysics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ee2fcec5499d97bdd632922523005704"><gtr:id>ee2fcec5499d97bdd632922523005704</gtr:id><gtr:otherNames>Cicero DO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1085-9195</gtr:issn><gtr:outcomeId>51EC76A98D9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8A600CB7-2850-4C99-8B16-E06C4FBE5342</gtr:id><gtr:title>Negative regulation of the Hippo pathway by E3 ubiquitin ligase ITCH is sufficient to promote tumorigenicity.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4205cf8eadda96c8bba776a7f73f3d12"><gtr:id>4205cf8eadda96c8bba776a7f73f3d12</gtr:id><gtr:otherNames>Salah Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>FnPcYyfdRQp</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EB088190-4D5C-4C85-A9D6-194C81FCDA56</gtr:id><gtr:title>Transglutaminase 3 Protects against Photodamage.</gtr:title><gtr:parentPublicationTitle>The Journal of investigative dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c47d19096ab66b652d442f4194124d17"><gtr:id>c47d19096ab66b652d442f4194124d17</gtr:id><gtr:otherNames>Frezza V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-202X</gtr:issn><gtr:outcomeId>5aaa6710052002.75869746</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AFC64A9C-BC98-4833-B0D5-2979725BE1C4</gtr:id><gtr:title>Recognition mechanism of p63 by the E3 ligase Itch: novel strategy in the study and inhibition of this interaction.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ab7a486be5391b20fee16b0830ba8c78"><gtr:id>ab7a486be5391b20fee16b0830ba8c78</gtr:id><gtr:otherNames>Bellomaria A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>pm_12587_27_22935697</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>55D55A52-EAA0-4733-94A2-F047DFD06191</gtr:id><gtr:title>A novel extracellular role for tissue transglutaminase in matrix-bound VEGF-mediated angiogenesis.</gtr:title><gtr:parentPublicationTitle>Cell death &amp; disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/904f884f2cedac3bc8311c15aeb35f7b"><gtr:id>904f884f2cedac3bc8311c15aeb35f7b</gtr:id><gtr:otherNames>Wang Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>pm_12587_27_24052076</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FF42B9C2-C238-4E26-B2C0-63B95FF76C58</gtr:id><gtr:title>Rapamycin regulates biochemical metabolites.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/11b8def079cf2505dd3d25563d4fcb61"><gtr:id>11b8def079cf2505dd3d25563d4fcb61</gtr:id><gtr:otherNames>Tucci P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>pm_12587_27_23839040</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1722184-2CB8-4C9C-B0B8-404E35C3A513</gtr:id><gtr:title>KMTase Set7/9 is a critical regulator of E2F1 activity upon genotoxic stress.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/867bb8a30b5c8f47afb401aa4b34c62f"><gtr:id>867bb8a30b5c8f47afb401aa4b34c62f</gtr:id><gtr:otherNames>Lezina L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>545fa6f38fcb91.38749392</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CAB7EE4A-20CD-4A87-86FF-D3A47366AE6C</gtr:id><gtr:title>Vascular ageing and endothelial cell senescence: Molecular mechanisms of physiology and diseases.</gtr:title><gtr:parentPublicationTitle>Mechanisms of ageing and development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0b80ca2434b105038ead2cf2c4de2ec6"><gtr:id>0b80ca2434b105038ead2cf2c4de2ec6</gtr:id><gtr:otherNames>Regina C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0047-6374</gtr:issn><gtr:outcomeId>58c6cdfe43d301.98038938</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7DE98D18-81AF-4C5F-BEDC-71A1DE294373</gtr:id><gtr:title>Knuckle pads, in an epidermal palmoplantar keratoderma patient with Keratin 9 R163W transgrediens expression.</gtr:title><gtr:parentPublicationTitle>European journal of dermatology : EJD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/819a7a3e4603be8e62024eb809e796b1"><gtr:id>819a7a3e4603be8e62024eb809e796b1</gtr:id><gtr:otherNames>Codispoti A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1167-1122</gtr:issn><gtr:outcomeId>0F168B280A6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F41BFFF-7D42-4E32-9BF5-6327E9437969</gtr:id><gtr:title>Tissue transglutaminase (TG2) facilitates phosphatidylserine exposure and calpain activity in calcium-induced death of erythrocytes.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3fb237287a90078d264ffe6aa7585794"><gtr:id>3fb237287a90078d264ffe6aa7585794</gtr:id><gtr:otherNames>Sarang Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>5C147B361A7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EA071E0A-11B6-42C3-B2B0-B1F8A7CCF9CF</gtr:id><gtr:title>TAp73 upregulates IL-1? in cancer cells: Potential biomarker in lung and breast cancer?</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be5ba5e9d2271c9d7c6c096ca744836c"><gtr:id>be5ba5e9d2271c9d7c6c096ca744836c</gtr:id><gtr:otherNames>Vikhreva P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn><gtr:outcomeId>58c6cdfd7dfbe4.99929012</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>819FCBD9-74C4-4673-A1E6-62B1F8328700</gtr:id><gtr:title>The impact of p53 and p73 on aneuploidy and cancer.</gtr:title><gtr:parentPublicationTitle>Trends in cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad49b2228bb35fb6073bb749ba051fd7"><gtr:id>ad49b2228bb35fb6073bb749ba051fd7</gtr:id><gtr:otherNames>Tomasini R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0962-8924</gtr:issn><gtr:outcomeId>448613197F7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F54E9AE7-B9D9-4DD5-8273-B7E6D10F08A1</gtr:id><gtr:title>Skn-1a/Oct-11 and ?Np63a exert antagonizing effects on human keratin expression.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8cb8d55f2ed73e9941c053cd7fb914e2"><gtr:id>8cb8d55f2ed73e9941c053cd7fb914e2</gtr:id><gtr:otherNames>Lena AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn><gtr:outcomeId>EQhS7iythc9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A5F91029-F51E-4BEB-9B42-3A38D3341A72</gtr:id><gtr:title>Salivary miRNAome profiling uncovers epithelial and proliferative miRNAs with differential expression across dentition stages.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/09c0f58673cbe7af98774f2addbf8e73"><gtr:id>09c0f58673cbe7af98774f2addbf8e73</gtr:id><gtr:otherNames>Formosa A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>CUWv12eu1YE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B97F445-71C0-4C47-AE0A-95F9B9AF29DA</gtr:id><gtr:title>p63 in tooth development.</gtr:title><gtr:parentPublicationTitle>Biochemical pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d22fc1f6855fc0c192fe4e566ef0a2bd"><gtr:id>d22fc1f6855fc0c192fe4e566ef0a2bd</gtr:id><gtr:otherNames>Rufini A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-2952</gtr:issn><gtr:outcomeId>JRj1S9hM3uM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>38A30318-A2F2-46CA-BB31-DBE93AC1D93C</gtr:id><gtr:title>Damage limitation.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8202ec23ce7877b2a6c8080563ce1fe"><gtr:id>f8202ec23ce7877b2a6c8080563ce1fe</gtr:id><gtr:otherNames>Amelio I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>58c6ce006b24c2.33792974</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0F16AC80-9A0A-4080-B663-7DFB2E518D20</gtr:id><gtr:title>p63 is a suppressor of tumorigenesis and metastasis interacting with mutant p53.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/15a25fc8d85639e9e4f6c3b56a2a6100"><gtr:id>15a25fc8d85639e9e4f6c3b56a2a6100</gtr:id><gtr:otherNames>Melino G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>E2Mp69HFefQ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E3F8FB2-A261-44FB-A06F-AA009B3EF09D</gtr:id><gtr:title>Genome-editing tools for stem cell biology.</gtr:title><gtr:parentPublicationTitle>Cell death &amp; disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a49b58609105648b7314e4137962a550"><gtr:id>a49b58609105648b7314e4137962a550</gtr:id><gtr:otherNames>Vasileva EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56cb40e612f217.74866393</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5EAFD4B2-63B4-437E-9F67-3821C4E95C38</gtr:id><gtr:title>Analysis of the oligomeric state and transactivation potential of TAp73a.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/97541fb0382ce1c6655b62c222c24996"><gtr:id>97541fb0382ce1c6655b62c222c24996</gtr:id><gtr:otherNames>Luh LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>pm_12587_27_23538419</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>46F321D5-FF63-4424-9853-94115212BF98</gtr:id><gtr:title>MicroRNA 217 modulates endothelial cell senescence via silent information regulator 1.</gtr:title><gtr:parentPublicationTitle>Circulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d321fd301d57e75c0badfab189928b82"><gtr:id>d321fd301d57e75c0badfab189928b82</gtr:id><gtr:otherNames>Menghini R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0009-7322</gtr:issn><gtr:outcomeId>CE9B5F9DE87</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0A5EB397-C8B4-4348-BE27-2E1453C73993</gtr:id><gtr:title>KMT Set7/9 affects genotoxic stress response via the Mdm2 axis.</gtr:title><gtr:parentPublicationTitle>Oncotarget</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/867bb8a30b5c8f47afb401aa4b34c62f"><gtr:id>867bb8a30b5c8f47afb401aa4b34c62f</gtr:id><gtr:otherNames>Lezina L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1949-2553</gtr:issn><gtr:outcomeId>56cb40e3552e31.60037350</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F0FA4134-EA97-4EE6-AFB1-06C0CC8DA677</gtr:id><gtr:title>Functions of TAp63 and p53 in restraining the development of metastatic cancer.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc2f1e10d6f3dc4b0c5af4f12ceca137"><gtr:id>bc2f1e10d6f3dc4b0c5af4f12ceca137</gtr:id><gtr:otherNames>Tan EH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>pm_12587_27_23873029</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A7909D4E-CB1D-4ACE-8ECC-30647E5D9C65</gtr:id><gtr:title>Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f446e86d6836d8e6a5da49dfe563b87"><gtr:id>8f446e86d6836d8e6a5da49dfe563b87</gtr:id><gtr:otherNames>Galluzzi L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>T1phNr4m6hW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EF52EDB3-04A5-4663-B0E1-443580F67135</gtr:id><gtr:title>?Np63 targets cytoglobin to inhibit oxidative stress-induced apoptosis in keratinocytes and lung cancer.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3550492275703601c3c0d71345a9c995"><gtr:id>3550492275703601c3c0d71345a9c995</gtr:id><gtr:otherNames>Latina A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>56cb40e6d71706.24763955</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA38E761-A155-4BC3-A5B3-1ED8BE7635D5</gtr:id><gtr:title>Scotin: A new p63 target gene expressed during epidermal differentiation.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7f6b482a55caf5f3215dac6e0f40b06f"><gtr:id>7f6b482a55caf5f3215dac6e0f40b06f</gtr:id><gtr:otherNames>Zocchi L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn><gtr:outcomeId>290F21057A7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF3D4737-C78B-48AA-8289-CA1DBCD8A0F5</gtr:id><gtr:title>P73 and caspase-cleaved p73 fragments localize to mitochondria and augment TRAIL-induced apoptosis.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/532598b98b028a69feb3aaf7c4089099"><gtr:id>532598b98b028a69feb3aaf7c4089099</gtr:id><gtr:otherNames>Sayan AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>CD34992FABC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1263E513-0DE5-4A4F-99A6-ACF012118F30</gtr:id><gtr:title>A cytoplasmic PML mutant inhibits p53 function.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a1448bee0ae56bd58fecff6db43339f5"><gtr:id>a1448bee0ae56bd58fecff6db43339f5</gtr:id><gtr:otherNames>Bellodi C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>8BEC69B7C2A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E44A6B9F-1818-4E0D-AC54-939A07936FF7</gtr:id><gtr:title>Setdb1, a novel interactor of ?Np63, is involved in breast tumorigenesis.</gtr:title><gtr:parentPublicationTitle>Oncotarget</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0b80ca2434b105038ead2cf2c4de2ec6"><gtr:id>0b80ca2434b105038ead2cf2c4de2ec6</gtr:id><gtr:otherNames>Regina C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1949-2553</gtr:issn><gtr:outcomeId>58c6ce00b8c9f4.84454551</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7AC9EB5F-B117-4E2F-9FB9-CE76A87DC0A8</gtr:id><gtr:title>Molecular dynamics of the full-length p53 monomer.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c2d32ba481cac8c9d4b86952cd56b122"><gtr:id>c2d32ba481cac8c9d4b86952cd56b122</gtr:id><gtr:otherNames>Chillemi G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>pm_12587_27_23974096</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E371A615-FF2F-49A1-B084-0F00D9BC4F5A</gtr:id><gtr:title>TAp73 opposes tumor angiogenesis by promoting hypoxia-inducible factor 1a degradation.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8202ec23ce7877b2a6c8080563ce1fe"><gtr:id>f8202ec23ce7877b2a6c8080563ce1fe</gtr:id><gtr:otherNames>Amelio I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>56cb40e85577e0.68554700</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A702950-9ED3-45ED-BFE5-8A8A765AE952</gtr:id><gtr:title>Maintaining epithelial stemness with p63.</gtr:title><gtr:parentPublicationTitle>Science signaling</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/15a25fc8d85639e9e4f6c3b56a2a6100"><gtr:id>15a25fc8d85639e9e4f6c3b56a2a6100</gtr:id><gtr:otherNames>Melino G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1945-0877</gtr:issn><gtr:outcomeId>56cb40e5db64c0.46753819</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A777A209-8B22-42BE-9280-E62B60D79C7E</gtr:id><gtr:title>The human squamous epithelial cell envelope: the structural model by Peter M Steinert.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf02bfffc596a84b2aa376016aa486ba"><gtr:id>cf02bfffc596a84b2aa376016aa486ba</gtr:id><gtr:otherNames>Candi E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>pm_12587_27_23832145</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>33E2CB35-9354-43C3-9337-E8A73FE53CB1</gtr:id><gtr:title>p73, miR106b, miR34a, and Itch in chronic lymphocytic leukemia.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/247414815407f8c50511cf613d791a43"><gtr:id>247414815407f8c50511cf613d791a43</gtr:id><gtr:otherNames>Rivetti di Val Cervo P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>07C9A61E161</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>671F2BA4-6252-486D-8160-B787090E8B8D</gtr:id><gtr:title>The E3 ubiquitin ligase Itch controls the protein stability of p63.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5ee5a13f7d6b0787d4919dd19ba893a"><gtr:id>c5ee5a13f7d6b0787d4919dd19ba893a</gtr:id><gtr:otherNames>Rossi M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>881727D585F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>036EFFC4-85AA-4FBB-9A2E-43520185C6BB</gtr:id><gtr:title>p63 Adjusts Sugar Taste of Epidermal&amp;nbsp;Layers.</gtr:title><gtr:parentPublicationTitle>The Journal of investigative dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8202ec23ce7877b2a6c8080563ce1fe"><gtr:id>f8202ec23ce7877b2a6c8080563ce1fe</gtr:id><gtr:otherNames>Amelio I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-202X</gtr:issn><gtr:outcomeId>5aaa66674e07f3.82055583</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D48FE117-E8CD-4D86-93ED-EC5E9EA67D25</gtr:id><gtr:title>miR-203 represses 'stemness' by repressing DeltaNp63.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8cb8d55f2ed73e9941c053cd7fb914e2"><gtr:id>8cb8d55f2ed73e9941c053cd7fb914e2</gtr:id><gtr:otherNames>Lena AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>1F30F533823</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B88800D2-203E-4793-8E0E-963AC9E57E2C</gtr:id><gtr:title>TAp73 is required for spermatogenesis and the maintenance of male fertility.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/75863d44d38390b793a438ac87b9f44b"><gtr:id>75863d44d38390b793a438ac87b9f44b</gtr:id><gtr:otherNames>Inoue S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>545fa6f2045d26.22173350</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>09C21B0A-A22A-40A0-906E-AC7C7E986A19</gtr:id><gtr:title>New p63 targets in keratinocytes identified by a genome-wide approach.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9dec1cd62c9b09e4b326514480134493"><gtr:id>9dec1cd62c9b09e4b326514480134493</gtr:id><gtr:otherNames>Vigan? MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>26629F79029</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EE3B50E7-D021-4FEF-98BD-CF573FEA99F8</gtr:id><gtr:title>Tissue transglutaminase (TG2) protects cardiomyocytes against ischemia/reperfusion injury by regulating ATP synthesis.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/764fbe682d60b3aca7b1a88bc40c7654"><gtr:id>764fbe682d60b3aca7b1a88bc40c7654</gtr:id><gtr:otherNames>Szondy Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>AE4A048F108</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13DCAD60-841F-4071-B972-9971C42B48C0</gtr:id><gtr:title>Neuronal differentiation by TAp73 is mediated by microRNA-34a regulation of synaptic protein targets.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dde82fd63c3f14b67506477d6f570a6a"><gtr:id>dde82fd63c3f14b67506477d6f570a6a</gtr:id><gtr:otherNames>Agostini M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_12587_27_22160687</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F29CEB67-976D-42D9-AF7B-A75E50ABB281</gtr:id><gtr:title>Tissue transglutaminase does not affect fibrotic matrix stability or regression of liver fibrosis in mice.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/da95fbdca04fada64e6f9812ad046c56"><gtr:id>da95fbdca04fada64e6f9812ad046c56</gtr:id><gtr:otherNames>Popov Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>g7vRNSGrtAW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>416E2456-A7F0-48E5-A674-80898446C042</gtr:id><gtr:title>The adenine nucleotide translocator 1 acts as a type 2 transglutaminase substrate: implications for mitochondrial-dependent apoptosis.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4a6c8bf583ac107e964d948ef16b8913"><gtr:id>4a6c8bf583ac107e964d948ef16b8913</gtr:id><gtr:otherNames>Malorni W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>7ABBE7138F1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8831B41D-8F68-414A-B57E-D3A72FD0BA21</gtr:id><gtr:title>The p53 Family in Brain Disease.</gtr:title><gtr:parentPublicationTitle>Antioxidants &amp; redox signaling</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dde82fd63c3f14b67506477d6f570a6a"><gtr:id>dde82fd63c3f14b67506477d6f570a6a</gtr:id><gtr:otherNames>Agostini M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1523-0864</gtr:issn><gtr:outcomeId>5aaa6666472464.83523053</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F76C682D-24BE-432E-85B6-13208BCDB275</gtr:id><gtr:title>AMP-activated protein kinase: structure, function, and role in pathological processes.</gtr:title><gtr:parentPublicationTitle>Biochemistry. Biokhimiia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cb84266859eb9a4fffc1b046220ea1cf"><gtr:id>cb84266859eb9a4fffc1b046220ea1cf</gtr:id><gtr:otherNames>Novikova DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-2979</gtr:issn><gtr:outcomeId>56cb40e830a3d2.95326531</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4B0A0287-F463-4054-B63F-A5407E983557</gtr:id><gtr:title>Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f446e86d6836d8e6a5da49dfe563b87"><gtr:id>8f446e86d6836d8e6a5da49dfe563b87</gtr:id><gtr:otherNames>Galluzzi L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>FBD161400D9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E0EA4A9C-D521-4FB6-92AB-6584951C9D11</gtr:id><gtr:title>Transglutaminase 2 null macrophages respond to lipopolysaccharide stimulation by elevated proinflammatory cytokine production due to an enhanced av?3 integrin-induced Src tyrosine kinase signaling.</gtr:title><gtr:parentPublicationTitle>Immunology letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3fb237287a90078d264ffe6aa7585794"><gtr:id>3fb237287a90078d264ffe6aa7585794</gtr:id><gtr:otherNames>Sarang Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0165-2478</gtr:issn><gtr:outcomeId>SzrpkV3tnpE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>81CBBCE1-01D9-4A8B-992F-21C479CF137F</gtr:id><gtr:title>Isoform-specific p73 knockout mice reveal a novel role for delta Np73 in the DNA damage response pathway.</gtr:title><gtr:parentPublicationTitle>Genes &amp; development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e8122afa8a35e4fd15f9c5a56729ce6f"><gtr:id>e8122afa8a35e4fd15f9c5a56729ce6f</gtr:id><gtr:otherNames>Wilhelm MT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0890-9369</gtr:issn><gtr:outcomeId>Y3DstPhrd8H</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0657AEA4-69D7-4F77-86E6-5E4E11F20608</gtr:id><gtr:title>The &amp;quot;Sharp&amp;quot; blade against HIF-mediated metastasis.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8202ec23ce7877b2a6c8080563ce1fe"><gtr:id>f8202ec23ce7877b2a6c8080563ce1fe</gtr:id><gtr:otherNames>Amelio I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>pm_12587_27_23187809</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1FEFBE1-4A94-4723-AAE2-81B44FCFACBB</gtr:id><gtr:title>Senescence and aging: the critical roles of p53.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d22fc1f6855fc0c192fe4e566ef0a2bd"><gtr:id>d22fc1f6855fc0c192fe4e566ef0a2bd</gtr:id><gtr:otherNames>Rufini A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>pm_12587_27_23416979</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF74C27C-879C-4204-9D80-B870E8685113</gtr:id><gtr:title>Essential versus accessory aspects of cell death: recommendations of the NCCD 2015.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f446e86d6836d8e6a5da49dfe563b87"><gtr:id>8f446e86d6836d8e6a5da49dfe563b87</gtr:id><gtr:otherNames>Galluzzi L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>545fa6f4130ef9.27548330</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>260C8F6D-9405-4AE8-8D16-38913FC5D49B</gtr:id><gtr:title>p73 regulates maintenance of neural stem cell.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dde82fd63c3f14b67506477d6f570a6a"><gtr:id>dde82fd63c3f14b67506477d6f570a6a</gtr:id><gtr:otherNames>Agostini M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn><gtr:outcomeId>T6T8nUCaQUs</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4ED67461-B671-4F3E-962F-7747553B8C09</gtr:id><gtr:title>High throughput screening for inhibitors of the HECT ubiquitin E3 ligase ITCH identifies antidepressant drugs as regulators of autophagy.</gtr:title><gtr:parentPublicationTitle>Cell death &amp; disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5ee5a13f7d6b0787d4919dd19ba893a"><gtr:id>c5ee5a13f7d6b0787d4919dd19ba893a</gtr:id><gtr:otherNames>Rossi M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>545fa6f368c1b7.86670818</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>05B05FA2-A47C-48C6-AA05-C9E3265829F7</gtr:id><gtr:title>Role of p63 and the Notch pathway in cochlea development and sensorineural deafness.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/06b1423b928b03697c3b3a2bf7ba1027"><gtr:id>06b1423b928b03697c3b3a2bf7ba1027</gtr:id><gtr:otherNames>Terrinoni A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_12587_27_23589895</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>45F92BD8-014C-4C7F-83C1-7072C65019F3</gtr:id><gtr:title>Carmine Melino and the Institute of Hygiene.</gtr:title><gtr:parentPublicationTitle>Annali di igiene : medicina preventiva e di comunita</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/15a25fc8d85639e9e4f6c3b56a2a6100"><gtr:id>15a25fc8d85639e9e4f6c3b56a2a6100</gtr:id><gtr:otherNames>Melino G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1120-9135</gtr:issn><gtr:outcomeId>5aaa66666a53e7.99886365</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>370A8D53-C172-4A7D-B883-6D5336C23D38</gtr:id><gtr:title>Caspase cleavage of Itch in chronic lymphocytic leukemia cells.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5ee5a13f7d6b0787d4919dd19ba893a"><gtr:id>c5ee5a13f7d6b0787d4919dd19ba893a</gtr:id><gtr:otherNames>Rossi M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn><gtr:outcomeId>29FBBE566F2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A15B171F-F789-4D7C-8B59-A373E526C227</gtr:id><gtr:title>Guidelines for the use and interpretation of assays for monitoring autophagy.</gtr:title><gtr:parentPublicationTitle>Autophagy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3338e204a3c58e1fab88cb3342a71645"><gtr:id>3338e204a3c58e1fab88cb3342a71645</gtr:id><gtr:otherNames>Klionsky DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1554-8627</gtr:issn><gtr:outcomeId>pm_12587_27_22966490</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9038029C-DC77-4EF8-85C9-E834310E9CDA</gtr:id><gtr:title>7th Tuscany Retreat on Cancer Research: genetic profiling, resistance mechanism and novel treatment concepts in cancer.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/83369a22ab3fb1e1b52ad46657795909"><gtr:id>83369a22ab3fb1e1b52ad46657795909</gtr:id><gtr:otherNames>Leprivier G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>pm_12587_27_22179574</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E362534-3946-4DDA-843D-2C91D5D6C345</gtr:id><gtr:title>miR-146a is modulated in human endothelial cell with aging.</gtr:title><gtr:parentPublicationTitle>Atherosclerosis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ae048fc94db32bb585b066fa8a9c670"><gtr:id>2ae048fc94db32bb585b066fa8a9c670</gtr:id><gtr:otherNames>Vasa-Nicotera M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9150</gtr:issn><gtr:outcomeId>LozBCmcbCwc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA482C95-0A7F-466F-AA76-BFD546D09AFF</gtr:id><gtr:title>Matrix changes induced by transglutaminase 2 lead to inhibition of angiogenesis and tumor growth.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1a2734ab5008a3db6b1f0419dabba17f"><gtr:id>1a2734ab5008a3db6b1f0419dabba17f</gtr:id><gtr:otherNames>Jones RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>07A4D1C3232</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>33D00CD7-B8FD-49AD-A4BA-215441B81D37</gtr:id><gtr:title>p53MutaGene: an online tool to estimate the effect of p53 mutational status on gene regulation in cancer.</gtr:title><gtr:parentPublicationTitle>Cell death &amp; disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8202ec23ce7877b2a6c8080563ce1fe"><gtr:id>f8202ec23ce7877b2a6c8080563ce1fe</gtr:id><gtr:otherNames>Amelio I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58c6ced2cc5451.04740236</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D82AEDD1-1411-4F44-B52A-4023A370A1F3</gtr:id><gtr:title>Cell death pathology: cross-talk with autophagy and its clinical implications.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8202ec23ce7877b2a6c8080563ce1fe"><gtr:id>f8202ec23ce7877b2a6c8080563ce1fe</gtr:id><gtr:otherNames>Amelio I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn><gtr:outcomeId>aHCC6pv2UvF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C4A2FF80-9D76-4D06-B003-93C35706BD6C</gtr:id><gtr:title>Novel and recurrent ALDH3A2 mutations in Italian patients with Sj&amp;ouml;gren-Larsson syndrome.</gtr:title><gtr:parentPublicationTitle>Journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d8297d1ee56b391b038008605aed0df3"><gtr:id>d8297d1ee56b391b038008605aed0df3</gtr:id><gtr:otherNames>Didona B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1434-5161</gtr:issn><gtr:outcomeId>ADF76A78334</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DE2C76D1-4920-45C2-ADFA-F03C12256FF0</gtr:id><gtr:title>Chemotherapy-induced apoptosis in hepatocellular carcinoma involves the p53 family and is mediated via the extrinsic and the intrinsic pathway.</gtr:title><gtr:parentPublicationTitle>International journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/af2fc48d97b909a04a6238ea602779d5"><gtr:id>af2fc48d97b909a04a6238ea602779d5</gtr:id><gtr:otherNames>Seitz SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0020-7136</gtr:issn><gtr:outcomeId>2F34DBBBBA9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>117E2D0D-8690-4D30-8583-3F9D19562904</gtr:id><gtr:title>Induction of apoptosis by IFN? in human neuroblastoma cell lines through the CD95/CD95L autocrine circuit.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7876abe36dc197edd850bcd158433472"><gtr:id>7876abe36dc197edd850bcd158433472</gtr:id><gtr:otherNames>Bernassola F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>56cb40e43f5bb3.98074206</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6C991B88-DFC3-449A-915F-AE69ED9C77B1</gtr:id><gtr:title>TAp63 is important for cardiac differentiation of embryonic stem cells and heart development.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40e0609fc93b73bec0fc618254de47b1"><gtr:id>40e0609fc93b73bec0fc618254de47b1</gtr:id><gtr:otherNames>Rouleau M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>hr8o3hGUSSc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9C03F7F6-8D39-4FE8-8416-3E9B0135F139</gtr:id><gtr:title>TAp63gamma is required for the late stages of myogenesis.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/498a0238af842e333e28a4b8a5c75400"><gtr:id>498a0238af842e333e28a4b8a5c75400</gtr:id><gtr:otherNames>Cefal? S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>56cb40e89726f2.54028052</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>75B8380B-BAC8-468E-9D60-7CD5DB05535B</gtr:id><gtr:title>Relation of Stroke and Bleeding Risk Profiles to Efficacy and Safety of Edoxaban for Cardioversion of Atrial Fibrillation (from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation [ENSURE-AF] Study).</gtr:title><gtr:parentPublicationTitle>The American journal of cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cb84f4ac18942d2d2008bdc3eaef089f"><gtr:id>cb84f4ac18942d2d2008bdc3eaef089f</gtr:id><gtr:otherNames>Lip GYH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0002-9149</gtr:issn><gtr:outcomeId>5aaa66644c66f7.21395793</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>94B2C1B5-3114-4DA7-A111-2DB6CEB363E2</gtr:id><gtr:title>The flick of a switch: which death program to choose?</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b1f6b5f0847d85dd10300d326a93396"><gtr:id>9b1f6b5f0847d85dd10300d326a93396</gtr:id><gtr:otherNames>Vandenabeele P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>pm_12587_27_22684093</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EB296919-545A-4332-85A6-6BB9D7DA2BD4</gtr:id><gtr:title>Type 2 transglutaminase is involved in the autophagy-dependent clearance of ubiquitinated proteins.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b68d4a44c2284d1967609344637ababf"><gtr:id>b68d4a44c2284d1967609344637ababf</gtr:id><gtr:otherNames>D'Eletto M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>pm_12587_27_22322858</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>91623284-2B21-4015-B337-9126ECAFC684</gtr:id><gtr:title>Proapoptotic modification of substituted isoindolinones as MDM2-p53 inhibitors.</gtr:title><gtr:parentPublicationTitle>Bioorganic &amp; medicinal chemistry letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2665b33b31ff39b3d1f95d48ff793eb2"><gtr:id>2665b33b31ff39b3d1f95d48ff793eb2</gtr:id><gtr:otherNames>Grigoreva TA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0960-894X</gtr:issn><gtr:outcomeId>5aaa66658c3353.31148103</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D46220AD-A8CE-4835-8736-C60DF4A99D3E</gtr:id><gtr:title>Mule/Huwe1/Arf-BP1 suppresses Ras-driven tumorigenesis by preventing c-Myc/Miz1-mediated down-regulation of p21 and p15.</gtr:title><gtr:parentPublicationTitle>Genes &amp; development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/75863d44d38390b793a438ac87b9f44b"><gtr:id>75863d44d38390b793a438ac87b9f44b</gtr:id><gtr:otherNames>Inoue S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0890-9369</gtr:issn><gtr:outcomeId>pm_12587_27_23699408</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4D2813ED-D8AF-4372-A822-92BF55E8345F</gtr:id><gtr:title>Degradation of p63 by Itch.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/15a25fc8d85639e9e4f6c3b56a2a6100"><gtr:id>15a25fc8d85639e9e4f6c3b56a2a6100</gtr:id><gtr:otherNames>Melino G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>E5511378C77</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B990480-A50B-405C-9AF7-D3A0A023FA8B</gtr:id><gtr:title>DRUGSURV: a resource for repositioning of approved and experimental drugs in oncology based on patient survival information.</gtr:title><gtr:parentPublicationTitle>Cell death &amp; disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8202ec23ce7877b2a6c8080563ce1fe"><gtr:id>f8202ec23ce7877b2a6c8080563ce1fe</gtr:id><gtr:otherNames>Amelio I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>545fa6f2539f22.93011716</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FFA09059-FC78-4C11-8A96-E4C3F66F0781</gtr:id><gtr:title>Caspase-1 is a novel target of p63 in tumor suppression.</gtr:title><gtr:parentPublicationTitle>Cell death &amp; disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2cd5d10f841c27e2f13c2b8f63b6c177"><gtr:id>2cd5d10f841c27e2f13c2b8f63b6c177</gtr:id><gtr:otherNames>Celardo I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>pm_12587_27_23703390</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>587FEE7D-57DC-4324-9117-2F93E67F04F4</gtr:id><gtr:title>miR-143 regulates hexokinase 2 expression in cancer cells.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9e4119986f75688fbc0aed5020f48894"><gtr:id>9e4119986f75688fbc0aed5020f48894</gtr:id><gtr:otherNames>Peschiaroli A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>pm_12587_27_22469988</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3E11E51E-E8BA-4A47-88A5-1A254EAAA3A3</gtr:id><gtr:title>Caspase-14 and epidermis maturation.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b45ae5185afec6d7a93b2151d1a43c8"><gtr:id>7b45ae5185afec6d7a93b2151d1a43c8</gtr:id><gtr:otherNames>Nicotera P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn><gtr:outcomeId>FC4C96558B1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DD2E456F-3DE4-4364-B90C-74AC84DE9767</gtr:id><gtr:title>p63 controls cell migration and invasion by transcriptional regulation of MTSS1.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/361ef09d10b05604c4d390ab5dea3ca3"><gtr:id>361ef09d10b05604c4d390ab5dea3ca3</gtr:id><gtr:otherNames>Giacobbe A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>56cb40e69cf634.83510863</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F7DDB7BA-7F8F-470C-9355-C0BE68106F35</gtr:id><gtr:title>Metabolic reprogramming during neuronal differentiation.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dde82fd63c3f14b67506477d6f570a6a"><gtr:id>dde82fd63c3f14b67506477d6f570a6a</gtr:id><gtr:otherNames>Agostini M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>58c6cdfe671846.56868276</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E4BA0442-01B0-4747-B862-602C7DB3120E</gtr:id><gtr:title>HACE1 reduces oxidative stress and mutant Huntingtin toxicity by promoting the NRF2 response.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/15f15e5a26ebf9d19327bfe518516dd0"><gtr:id>15f15e5a26ebf9d19327bfe518516dd0</gtr:id><gtr:otherNames>Rotblat B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>545fa6f27a2b65.57410488</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF75F1F4-1F0C-4C28-9455-E346F9D9968B</gtr:id><gtr:title>CRISPR: a new method for genetic engineering - a prokaryotic immune component may potentially open a new era of gene silencing.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8202ec23ce7877b2a6c8080563ce1fe"><gtr:id>f8202ec23ce7877b2a6c8080563ce1fe</gtr:id><gtr:otherNames>Amelio I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>545fa6f31f8644.92114995</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>77C8D667-A1A5-445F-85AE-487F982CC5A7</gtr:id><gtr:title>Actin-binding protein alpha-actinin 4 (ACTN4) is a transcriptional co-activator of RelA/p65 sub-unit of NF-kB.</gtr:title><gtr:parentPublicationTitle>Oncotarget</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/49490ffa0f4b0bce480985be36b01f50"><gtr:id>49490ffa0f4b0bce480985be36b01f50</gtr:id><gtr:otherNames>Aksenova V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1949-2553</gtr:issn><gtr:outcomeId>pm_12587_27_23482348</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C6F46E52-039B-4491-901C-E903A1F74D78</gtr:id><gtr:title>p73-mediated transcriptional activity is negatively regulated by polo-like kinase 1.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/16e0ae7f5b742a76adaacf5f51cf9f3e"><gtr:id>16e0ae7f5b742a76adaacf5f51cf9f3e</gtr:id><gtr:otherNames>Soond SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>C4C54AEB8CA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BDF7F87F-1E80-4C32-8048-7B45F05BB9D9</gtr:id><gtr:title>Nutrient availability links mitochondria, apoptosis, and obesity.</gtr:title><gtr:parentPublicationTitle>Aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/781f31cf4b37b7761c65c35e0c54f607"><gtr:id>781f31cf4b37b7761c65c35e0c54f607</gtr:id><gtr:otherNames>Pintus F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1945-4589</gtr:issn><gtr:outcomeId>pm_12587_27_23211444</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3F6265D4-6B2E-4A31-A9EA-5834D465F48F</gtr:id><gtr:title>Metabolic effects of TiO2 nanoparticles, a common component of sunscreens and cosmetics, on human keratinocytes.</gtr:title><gtr:parentPublicationTitle>Cell death &amp; disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/11b8def079cf2505dd3d25563d4fcb61"><gtr:id>11b8def079cf2505dd3d25563d4fcb61</gtr:id><gtr:otherNames>Tucci P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>pm_12587_27_23519118</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A83A451F-91AA-4B52-A088-ACED340063A3</gtr:id><gtr:title>The ubiquitin-specific protease USP47 is a novel beta-TRCP interactor regulating cell survival.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9e4119986f75688fbc0aed5020f48894"><gtr:id>9e4119986f75688fbc0aed5020f48894</gtr:id><gtr:otherNames>Peschiaroli A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>F94D73CDAA9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>82DC727C-7BA2-438F-9D48-82990205E516</gtr:id><gtr:title>Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1becf8e1906dc8afaa2dfc5594577991"><gtr:id>1becf8e1906dc8afaa2dfc5594577991</gtr:id><gtr:otherNames>Noto A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>5aaa666691ebc9.36985259</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2EA37467-2B23-46EC-B9AE-BE08A6CDC390</gtr:id><gtr:title>OTX1 expression in breast cancer is regulated by p53.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/06b1423b928b03697c3b3a2bf7ba1027"><gtr:id>06b1423b928b03697c3b3a2bf7ba1027</gtr:id><gtr:otherNames>Terrinoni A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>haxyfM7BmBV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B672F7DE-59C4-44A6-A971-5362275B484F</gtr:id><gtr:title>Integrin-?4 is a novel transcriptional target of TAp73.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8105283d9c1e7ec7d0489d67f5a15fb"><gtr:id>f8105283d9c1e7ec7d0489d67f5a15fb</gtr:id><gtr:otherNames>Xie N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>5aaa6664f1ccf5.73172756</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F1F6CE87-0142-4A50-822E-296360DBAB34</gtr:id><gtr:title>Tissue regeneration: The crosstalk between mesenchymal stem cells and immune response.</gtr:title><gtr:parentPublicationTitle>Cellular immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ed2edd8ff4e20c31d2e12d85021b915"><gtr:id>3ed2edd8ff4e20c31d2e12d85021b915</gtr:id><gtr:otherNames>Qi K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0008-8749</gtr:issn><gtr:outcomeId>5aaa666520b962.14568675</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F0A8B902-7CA1-47D0-8089-41FD55489B1C</gtr:id><gtr:title>MiR-203 controls proliferation, migration and invasive potential of prostate cancer cell lines.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e031c271351b66689cde41b23e8e02ba"><gtr:id>e031c271351b66689cde41b23e8e02ba</gtr:id><gtr:otherNames>Viticchi? G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>grugpXX2nUD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>16A7774B-5B95-4C32-9900-92DC5DC9D2BB</gtr:id><gtr:title>In the beginning there was RNA, then came transcription regulation: the Nobel Prize Lectures 2006.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/15a25fc8d85639e9e4f6c3b56a2a6100"><gtr:id>15a25fc8d85639e9e4f6c3b56a2a6100</gtr:id><gtr:otherNames>Melino G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>7325E6AD41B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AD27DE6B-7719-4C98-AD15-1DD756821E8E</gtr:id><gtr:title>p53 is upregulated in Alzheimer's disease and induces tau phosphorylation in HEK293a cells.</gtr:title><gtr:parentPublicationTitle>Neuroscience letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4215c217848c45eaa4c6f947d1263ba9"><gtr:id>4215c217848c45eaa4c6f947d1263ba9</gtr:id><gtr:otherNames>Hooper C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0304-3940</gtr:issn><gtr:outcomeId>E0D4CC982F2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C8D2A40C-A4EB-428E-A4CF-4DD970B990C1</gtr:id><gtr:title>PML involvement in the p73-mediated E1A-induced suppression of EGFR and induction of apoptosis in head and neck cancers.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a6d65294e81ceb791ff78c3899b18522"><gtr:id>a6d65294e81ceb791ff78c3899b18522</gtr:id><gtr:otherNames>Klanrit P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>2C93D98403E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>74B0D6FE-C879-4E1C-A8BC-8EBEB116D793</gtr:id><gtr:title>Induction of TAp63 by histone deacetylase inhibitors.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/965d8feba4031afcf8a01b411c83a7a0"><gtr:id>965d8feba4031afcf8a01b411c83a7a0</gtr:id><gtr:otherNames>Sayan BS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn><gtr:outcomeId>ca8wdPV9CGo</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>33411ED5-F1C3-42F6-96D4-12555EC4C3B5</gtr:id><gtr:title>Relative expression of TAp73 and ?Np73 isoforms.</gtr:title><gtr:parentPublicationTitle>Aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a5bce11b4bbb7a8c4c5cc2bb1c719551"><gtr:id>a5bce11b4bbb7a8c4c5cc2bb1c719551</gtr:id><gtr:otherNames>Conforti F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1945-4589</gtr:issn><gtr:outcomeId>pm_12587_27_22388545</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0AF6A15F-96F0-401A-86BE-8D4F50F32E46</gtr:id><gtr:title>p53 is cleaved by caspases generating fragments localizing to mitochondria.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/965d8feba4031afcf8a01b411c83a7a0"><gtr:id>965d8feba4031afcf8a01b411c83a7a0</gtr:id><gtr:otherNames>Sayan BS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>4406364383C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>91267C79-E395-4E6B-B976-BFDCF4BAB150</gtr:id><gtr:title>Active transcription of the human FAS/CD95/TNFRSF6 gene involves the p53 family.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7cfd72621f0d7c9131963eb2db7658cb"><gtr:id>7cfd72621f0d7c9131963eb2db7658cb</gtr:id><gtr:otherNames>Schilling T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn><gtr:outcomeId>A13F4F9ACEB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>598C3223-2B10-45A9-9CC1-227FB4C23807</gtr:id><gtr:title>Janus a god with two faces: death and survival utilise same mechanisms conserved by evolution.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b45ae5185afec6d7a93b2151d1a43c8"><gtr:id>7b45ae5185afec6d7a93b2151d1a43c8</gtr:id><gtr:otherNames>Nicotera P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>08DB71FB67A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>53F096DA-0E54-4209-92C5-F8BC4A385811</gtr:id><gtr:title>Over-expression of integrin beta3 can partially overcome the defect of integrin beta3 signaling in transglutaminase 2 null macrophages.</gtr:title><gtr:parentPublicationTitle>Immunology letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4e7b31c2455bd03300cd43f1f2e5a29a"><gtr:id>4e7b31c2455bd03300cd43f1f2e5a29a</gtr:id><gtr:otherNames>T?th B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0165-2478</gtr:issn><gtr:outcomeId>CF540B85A2A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BCE278FA-EFF9-4023-9BFA-926D9ED319D5</gtr:id><gtr:title>Modelling and molecular dynamics of the interaction between the E3 ubiquitin ligase Itch and the E2 UbcH7.</gtr:title><gtr:parentPublicationTitle>Biochemical pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b6876d484bc0b39f1e0bcd695cfa1e5b"><gtr:id>b6876d484bc0b39f1e0bcd695cfa1e5b</gtr:id><gtr:otherNames>Raimondo D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-2952</gtr:issn><gtr:outcomeId>18A6DC047E6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6D25CDF3-239B-4F2F-B825-D7FF57BB0AF1</gtr:id><gtr:title>Characterization of transglutaminase type II role in dendritic cell differentiation and function.</gtr:title><gtr:parentPublicationTitle>Journal of leukocyte biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c967aeac745ed9d23adaeac49e92894"><gtr:id>0c967aeac745ed9d23adaeac49e92894</gtr:id><gtr:otherNames>Matic I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0741-5400</gtr:issn><gtr:outcomeId>kqMuePgv13A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D851584-E014-4D00-BD62-EF53003F1EDB</gtr:id><gtr:title>Yes-associated protein (YAP) is a critical mediator of c-Jun-dependent apoptosis.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/21754945b6dccbe1ab44f4f33a694470"><gtr:id>21754945b6dccbe1ab44f4f33a694470</gtr:id><gtr:otherNames>Danovi SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>E5047D13FC5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>750C3C9C-6289-4886-B9ED-7BD03A5D25D8</gtr:id><gtr:title>PPISURV: a novel bioinformatics tool for uncovering the hidden role of specific genes in cancer survival outcome.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3f94a8475d91b280288b93fb65ec109e"><gtr:id>3f94a8475d91b280288b93fb65ec109e</gtr:id><gtr:otherNames>Antonov AV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>pm_12587_27_23686313</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4B489563-6088-4C99-A410-AE9E1ABB9F0E</gtr:id><gtr:title>Rita Levi-Montalcini 1909-2012</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/15a25fc8d85639e9e4f6c3b56a2a6100"><gtr:id>15a25fc8d85639e9e4f6c3b56a2a6100</gtr:id><gtr:otherNames>Melino G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>Zf67c5sKek6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DD154C22-B385-472F-9AEB-F10ABA6C31F2</gtr:id><gtr:title>p73 promotes glioblastoma cell invasion by directly activating POSTN (periostin) expression.</gtr:title><gtr:parentPublicationTitle>Oncotarget</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f21b0e2068cc66ca298b73771eefe30"><gtr:id>1f21b0e2068cc66ca298b73771eefe30</gtr:id><gtr:otherNames>Landr? V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1949-2553</gtr:issn><gtr:outcomeId>58c6ced3065723.29400508</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>86DF56C0-786B-4EC9-B7BF-2526CCF5F34B</gtr:id><gtr:title>Tumor suppressor WWOX binds to ?Np63a and sensitizes cancer cells to chemotherapy.</gtr:title><gtr:parentPublicationTitle>Cell death &amp; disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4205cf8eadda96c8bba776a7f73f3d12"><gtr:id>4205cf8eadda96c8bba776a7f73f3d12</gtr:id><gtr:otherNames>Salah Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>pm_12587_27_23370280</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AFA68B3E-EDC4-4732-BC89-39CC0916486A</gtr:id><gtr:title>FXIIIA and TGF-beta over-expression produces normal musculo-skeletal phenotype in TG2-/- mice.</gtr:title><gtr:parentPublicationTitle>Amino acids</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5fb05c10c29072870950f486f1358ca5"><gtr:id>5fb05c10c29072870950f486f1358ca5</gtr:id><gtr:otherNames>Tarantino U</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0939-4451</gtr:issn><gtr:outcomeId>E2B39A97B16</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9D6E9F8F-96AE-48F5-B912-1CDD69F9CEE1</gtr:id><gtr:title>p63 the guardian of human reproduction.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8202ec23ce7877b2a6c8080563ce1fe"><gtr:id>f8202ec23ce7877b2a6c8080563ce1fe</gtr:id><gtr:otherNames>Amelio I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>pm_12587_27_23165243</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4EA935E0-96C4-46F2-B8BB-46EF8C6B4C07</gtr:id><gtr:title>Expression of GATA-3 in epidermis and hair follicle: relationship to p63.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f030e9f9e8916f34d372eb7ab4769ac"><gtr:id>4f030e9f9e8916f34d372eb7ab4769ac</gtr:id><gtr:otherNames>Chikh A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn><gtr:outcomeId>297DDC04EE4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>51D8451D-F0AF-49B9-AFAE-B652CC15D7CA</gtr:id><gtr:title>p73 regulates serine biosynthesis in cancer.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8202ec23ce7877b2a6c8080563ce1fe"><gtr:id>f8202ec23ce7877b2a6c8080563ce1fe</gtr:id><gtr:otherNames>Amelio I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>pm_12587_27_24186203</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A48AC47C-A0AA-41DB-9555-EA1B324491F5</gtr:id><gtr:title>Lack of organ pathology in a mouse model of tissue transglutaminase autoimmunity</gtr:title><gtr:parentPublicationTitle>GASTROENTEROLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a0fbf6877a553611c2675481129fa2e9"><gtr:id>a0fbf6877a553611c2675481129fa2e9</gtr:id><gtr:otherNames>Freitag Tobias</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>18B5C8672B3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>15985269-BE7A-473F-9428-D193F26019B3</gtr:id><gtr:title>Ageing, neuronal connectivity and brain disorders: an unsolved ripple effect.</gtr:title><gtr:parentPublicationTitle>Molecular neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d3e194b1caac581a3ee75169d19ffbb"><gtr:id>6d3e194b1caac581a3ee75169d19ffbb</gtr:id><gtr:otherNames>Bano D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0893-7648</gtr:issn><gtr:outcomeId>BTpVDJSFbSb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B1616761-AB61-4023-B727-9F33C5CDAF9C</gtr:id><gtr:title>p73: a multifunctional protein in neurobiology.</gtr:title><gtr:parentPublicationTitle>Molecular neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b96d284a976e2e36fed8ef55107a549"><gtr:id>6b96d284a976e2e36fed8ef55107a549</gtr:id><gtr:otherNames>Killick R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0893-7648</gtr:issn><gtr:outcomeId>SwDKnPP6sq3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3DC1812E-D679-41C1-A33D-6BCD279A7ED2</gtr:id><gtr:title>Novel transglutaminase 1 mutations in patients affected by lamellar ichthyosis.</gtr:title><gtr:parentPublicationTitle>Cell death &amp; disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/06b1423b928b03697c3b3a2bf7ba1027"><gtr:id>06b1423b928b03697c3b3a2bf7ba1027</gtr:id><gtr:otherNames>Terrinoni A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>pm_12587_27_23096117</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8AE5FDE0-28AF-4E43-AE5E-58A085806067</gtr:id><gtr:title>microRNA-34a regulates neurite outgrowth, spinal morphology, and function.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dde82fd63c3f14b67506477d6f570a6a"><gtr:id>dde82fd63c3f14b67506477d6f570a6a</gtr:id><gtr:otherNames>Agostini M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_12587_27_22160706</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C7A1BBA1-735B-46E4-8241-C1438ED8BD1F</gtr:id><gtr:title>Tissue transglutaminase contributes to interstitial renal fibrosis by favoring accumulation of fibrillar collagen through TGF-beta activation and cell infiltration.</gtr:title><gtr:parentPublicationTitle>The American journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a576b10131174f0a7faa1e33ab002b31"><gtr:id>a576b10131174f0a7faa1e33ab002b31</gtr:id><gtr:otherNames>Shweke N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0002-9440</gtr:issn><gtr:outcomeId>A5B1C126221</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DB6564BD-1B72-48EC-B5AE-68266C49D8C7</gtr:id><gtr:title>Ultraconserved long non-coding RNA uc.63 in breast cancer.</gtr:title><gtr:parentPublicationTitle>Oncotarget</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f3fef18a6b677e078022f2d9017c066"><gtr:id>8f3fef18a6b677e078022f2d9017c066</gtr:id><gtr:otherNames>Marini A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1949-2553</gtr:issn><gtr:outcomeId>58c6cdff8faeb6.21838664</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>355B58BE-A426-4CFB-90D9-51E88B35AC66</gtr:id><gtr:title>TAp73 is required for macrophage-mediated innate immunity and the resolution of inflammatory responses.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad49b2228bb35fb6073bb749ba051fd7"><gtr:id>ad49b2228bb35fb6073bb749ba051fd7</gtr:id><gtr:otherNames>Tomasini R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>pm_12587_27_22976836</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B2AED7F-BDFA-4686-A988-FD95D3620DDF</gtr:id><gtr:title>Isoform-specific monoubiquitination, endocytosis, and degradation of alternatively spliced ErbB4 isoforms.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0f76d37699ed6b5cdf60c10692be898f"><gtr:id>0f76d37699ed6b5cdf60c10692be898f</gtr:id><gtr:otherNames>Sundvall M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>6C6ED7AD917</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7BE7E053-9D33-4326-8F66-877C139522B9</gtr:id><gtr:title>Connexin 26 (GJB2) mutations, causing KID Syndrome, are associated with cell death due to calcium gating deregulation.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/06b1423b928b03697c3b3a2bf7ba1027"><gtr:id>06b1423b928b03697c3b3a2bf7ba1027</gtr:id><gtr:otherNames>Terrinoni A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn><gtr:outcomeId>fDjn2eqqqbf</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C76DA72-2D1B-4C54-BCC4-3806496B38A2</gtr:id><gtr:title>Cutaneous mosaicism, in KRT1 pI479T patient, caused by the somatic loss of the wild-type allele, leads to the increase in local severity of the disease.</gtr:title><gtr:parentPublicationTitle>Journal of the European Academy of Dermatology and Venereology : JEADV</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3081b0b8581f7e474fc4d6d4974c35a6"><gtr:id>3081b0b8581f7e474fc4d6d4974c35a6</gtr:id><gtr:otherNames>Palombo R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0926-9959</gtr:issn><gtr:outcomeId>56cb40e798df20.86378534</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C4298549-707F-4251-98A6-D3B2D0EA403F</gtr:id><gtr:title>Itch: a HECT-type E3 ligase regulating immunity, skin and cancer.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/15a25fc8d85639e9e4f6c3b56a2a6100"><gtr:id>15a25fc8d85639e9e4f6c3b56a2a6100</gtr:id><gtr:otherNames>Melino G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>53832EB7853</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C98E87C0-54FD-45F3-967E-D7309CE6CF4E</gtr:id><gtr:title>GLS2 is transcriptionally regulated by p73 and contributes to neuronal differentiation.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f5b57a824c7e5fe82a148ee56800f03"><gtr:id>4f5b57a824c7e5fe82a148ee56800f03</gtr:id><gtr:otherNames>Velletri T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>pm_12587_27_24121663</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6458C2A7-9356-416F-A1EC-381984E11475</gtr:id><gtr:title>p63-microRNA feedback in keratinocyte senescence.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/247414815407f8c50511cf613d791a43"><gtr:id>247414815407f8c50511cf613d791a43</gtr:id><gtr:otherNames>Rivetti di Val Cervo P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_12587_27_22228303</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7F1D75DC-7B49-4CB1-9911-3D7A1657D093</gtr:id><gtr:title>p63 and p73, members of the p53 gene family, transactivate PKCdelta.</gtr:title><gtr:parentPublicationTitle>Biochemical pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/91990621650c46d98c5c49cce7ac4e71"><gtr:id>91990621650c46d98c5c49cce7ac4e71</gtr:id><gtr:otherNames>Ponassi R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0006-2952</gtr:issn><gtr:outcomeId>BE75DAD795A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E893C92-5EDA-43FD-8B6D-317AD4E3FF2A</gtr:id><gtr:title>Analysis of TAp73-dependent signaling via omics technologies.</gtr:title><gtr:parentPublicationTitle>Journal of proteome research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f058d209e9b9e4a33c3b924e1d046b5d"><gtr:id>f058d209e9b9e4a33c3b924e1d046b5d</gtr:id><gtr:otherNames>D'Alessandro A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1535-3893</gtr:issn><gtr:outcomeId>pm_12587_27_23919926</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1C31955F-7054-4979-B203-4BFF772B745D</gtr:id><gtr:title>Metabolic pathways regulated by p63.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf02bfffc596a84b2aa376016aa486ba"><gtr:id>cf02bfffc596a84b2aa376016aa486ba</gtr:id><gtr:otherNames>Candi E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn><gtr:outcomeId>58c6cdfda31dc1.81209265</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>388D3FC3-615C-4627-B1C0-11FA6739F21F</gtr:id><gtr:title>How Does p73 Cause Neuronal Defects?</gtr:title><gtr:parentPublicationTitle>Molecular neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b21c3c9674658143d31f9840ad2861f9"><gtr:id>b21c3c9674658143d31f9840ad2861f9</gtr:id><gtr:otherNames>Niklison-Chirou MV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0893-7648</gtr:issn><gtr:outcomeId>56cb40e54d8e66.11427057</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B9D6D077-5D2B-4F18-A832-5BC15184251E</gtr:id><gtr:title>Metabolic effect of TAp63a: enhanced glycolysis and pentose phosphate pathway, resulting in increased antioxidant defense.</gtr:title><gtr:parentPublicationTitle>Oncotarget</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f058d209e9b9e4a33c3b924e1d046b5d"><gtr:id>f058d209e9b9e4a33c3b924e1d046b5d</gtr:id><gtr:otherNames>D'Alessandro A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1949-2553</gtr:issn><gtr:outcomeId>545fa6f3d87381.27442215</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C2555D9-E9C2-4308-942E-28EC556A1C22</gtr:id><gtr:title>The E3 ligase Itch knockout mice show hyperproliferation and wound healing alteration.</gtr:title><gtr:parentPublicationTitle>The FEBS journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3b689d2032c3272d5ffc7193e54f2f04"><gtr:id>3b689d2032c3272d5ffc7193e54f2f04</gtr:id><gtr:otherNames>Giamboi-Miraglia A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1742-464X</gtr:issn><gtr:outcomeId>56cb40e10ae043.08816148</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41A49C3A-8EB6-44FC-BEBE-C5C787D78840</gtr:id><gtr:title>TAp73 is a marker of glutamine addiction in medulloblastoma.</gtr:title><gtr:parentPublicationTitle>Genes &amp; development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b21c3c9674658143d31f9840ad2861f9"><gtr:id>b21c3c9674658143d31f9840ad2861f9</gtr:id><gtr:otherNames>Niklison-Chirou MV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0890-9369</gtr:issn><gtr:outcomeId>5aaa6666026891.11804096</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7BA0C567-F4D5-40FA-8721-CF0E286DAB58</gtr:id><gtr:title>Polypharmacology of Approved Anticancer Drugs.</gtr:title><gtr:parentPublicationTitle>Current drug targets</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8202ec23ce7877b2a6c8080563ce1fe"><gtr:id>f8202ec23ce7877b2a6c8080563ce1fe</gtr:id><gtr:otherNames>Amelio I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1389-4501</gtr:issn><gtr:outcomeId>58c6cdfdc98126.81532663</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>66BDBC28-058D-4E6B-9BE0-84AEB8828694</gtr:id><gtr:title>Transglutaminase type II is involved in the pathogenesis of endotoxic shock.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e24ab831fc4db324422bc23859759feb"><gtr:id>e24ab831fc4db324422bc23859759feb</gtr:id><gtr:otherNames>Falasca L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>68F0990B61D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DE342E1E-9C3D-4D79-B69F-F7E465C79F24</gtr:id><gtr:title>MicroRNAs meet cell death.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/15a25fc8d85639e9e4f6c3b56a2a6100"><gtr:id>15a25fc8d85639e9e4f6c3b56a2a6100</gtr:id><gtr:otherNames>Melino G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>erJ8B4kmNot</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8ECB3E11-3DE5-48ED-9503-BA5BFB8F3BAF</gtr:id><gtr:title>miR-34: from bench to bedside.</gtr:title><gtr:parentPublicationTitle>Oncotarget</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dde82fd63c3f14b67506477d6f570a6a"><gtr:id>dde82fd63c3f14b67506477d6f570a6a</gtr:id><gtr:otherNames>Agostini M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1949-2553</gtr:issn><gtr:outcomeId>545fa781963ec3.56369003</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0599ADE8-F21F-47B3-AA96-37EBF6705F2A</gtr:id><gtr:title>Metabolic pathways regulated by TAp73 in response to oxidative stress.</gtr:title><gtr:parentPublicationTitle>Oncotarget</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dde82fd63c3f14b67506477d6f570a6a"><gtr:id>dde82fd63c3f14b67506477d6f570a6a</gtr:id><gtr:otherNames>Agostini M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1949-2553</gtr:issn><gtr:outcomeId>58c6ce0018f065.60718920</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1FF234E1-A597-42ED-B714-BE648B772586</gtr:id><gtr:title>Cell death pathology: perspective for human diseases.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dde82fd63c3f14b67506477d6f570a6a"><gtr:id>dde82fd63c3f14b67506477d6f570a6a</gtr:id><gtr:otherNames>Agostini M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn><gtr:outcomeId>n5E7y4cmea4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2FF885DB-504B-4441-A721-474B8D06009E</gtr:id><gtr:title>Inhibitor of apoptosis-stimulating protein of p53 (iASPP) prevents senescence and is required for epithelial stratification.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f00b4f2908b7aafecaeb19da04bf9d4"><gtr:id>4f00b4f2908b7aafecaeb19da04bf9d4</gtr:id><gtr:otherNames>Notari M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>nBaDYQmgwHq</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9AF93277-BE9D-4AA9-81CC-6B2BAF8D2976</gtr:id><gtr:title>Differential roles of p63 isoforms in epidermal development: selective genetic complementation in p63 null mice.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf02bfffc596a84b2aa376016aa486ba"><gtr:id>cf02bfffc596a84b2aa376016aa486ba</gtr:id><gtr:otherNames>Candi E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>33D1A712E32</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C4B39811-F3FC-4E33-B110-3B3B3EFAAF6C</gtr:id><gtr:title>miR-24 triggers epidermal differentiation by controlling actin adhesion and cell migration.</gtr:title><gtr:parentPublicationTitle>The Journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8202ec23ce7877b2a6c8080563ce1fe"><gtr:id>f8202ec23ce7877b2a6c8080563ce1fe</gtr:id><gtr:otherNames>Amelio I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-9525</gtr:issn><gtr:outcomeId>pm_12587_27_23071155</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>96BE02F6-206B-4170-B6D9-EAB724450396</gtr:id><gtr:title>Transglutaminase 2 kinase activity facilitates protein kinase A-induced phosphorylation of retinoblastoma protein.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7a7a993cb64f9d72196367fb90d1decf"><gtr:id>7a7a993cb64f9d72196367fb90d1decf</gtr:id><gtr:otherNames>Mishra S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>59BE2A09D35</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>692D6FD3-E8AB-48E1-B166-23BD893B722E</gtr:id><gtr:title>MicroRNAs and p63 in epithelial stemness.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf02bfffc596a84b2aa376016aa486ba"><gtr:id>cf02bfffc596a84b2aa376016aa486ba</gtr:id><gtr:otherNames>Candi E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>545fa6f3b3b859.25843159</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FFD4E090-65BF-4F1B-A32C-FDACB5053899</gtr:id><gtr:title>Transglutaminase 2 ablation leads to defective function of mitochondrial respiratory complex I affecting neuronal vulnerability in experimental models of extrapyramidal disorders.</gtr:title><gtr:parentPublicationTitle>Journal of neurochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d67fce3c8f17d0eea413d68f3f91fc8"><gtr:id>6d67fce3c8f17d0eea413d68f3f91fc8</gtr:id><gtr:otherNames>Battaglia G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn><gtr:outcomeId>B6AC4E6602A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7275A073-6BE1-45EA-B271-9D08927DBAC8</gtr:id><gtr:title>Differential control of TAp73 and DeltaNp73 protein stability by the ring finger ubiquitin ligase PIR2.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/965d8feba4031afcf8a01b411c83a7a0"><gtr:id>965d8feba4031afcf8a01b411c83a7a0</gtr:id><gtr:otherNames>Sayan BS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>fatcaqHarLh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>29576B1F-4F7E-46FC-9B7A-E516EAA8CC3B</gtr:id><gtr:title>Journal club. A cancer biologist weighs up p53, metabolism and cancer.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/15a25fc8d85639e9e4f6c3b56a2a6100"><gtr:id>15a25fc8d85639e9e4f6c3b56a2a6100</gtr:id><gtr:otherNames>Melino G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>TAH1as64Dun</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E7C02CA1-5ED5-477C-9450-1D5D4BEAC3CA</gtr:id><gtr:title>Policy and procedures on scientific misconduct.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/15a25fc8d85639e9e4f6c3b56a2a6100"><gtr:id>15a25fc8d85639e9e4f6c3b56a2a6100</gtr:id><gtr:otherNames>Melino G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>SbhH9YrUtti</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4D6F5A5F-434E-4F09-87A7-2B42430E9765</gtr:id><gtr:title>Metabolic profiling of visceral adipose tissue from obese subjects with or without metabolic syndrome.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf02bfffc596a84b2aa376016aa486ba"><gtr:id>cf02bfffc596a84b2aa376016aa486ba</gtr:id><gtr:otherNames>Candi E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>5aaa66649f0438.02298872</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C724DE95-E59E-49F1-9575-350944D68B2A</gtr:id><gtr:title>p73 Regulates Primary Cortical Neuron Metabolism: a Global Metabolic Profile.</gtr:title><gtr:parentPublicationTitle>Molecular neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dde82fd63c3f14b67506477d6f570a6a"><gtr:id>dde82fd63c3f14b67506477d6f570a6a</gtr:id><gtr:otherNames>Agostini M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0893-7648</gtr:issn><gtr:outcomeId>5aaa66671e2c97.34903231</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E1BE84AA-767B-4CA7-AF98-6106E23070AE</gtr:id><gtr:title>FOXM1 regulates proliferation, senescence and oxidative stress in keratinocytes and cancer cells.</gtr:title><gtr:parentPublicationTitle>Aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b1407e18c9dd495fb9379b4a29c486bc"><gtr:id>b1407e18c9dd495fb9379b4a29c486bc</gtr:id><gtr:otherNames>Smirnov A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1945-4589</gtr:issn><gtr:outcomeId>58c6cdffb6c717.30586341</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>91D4882F-7854-48C5-9EA3-C70704C22AAC</gtr:id><gtr:title>Differential regulated microRNA by wild type and mutant p53 in induced pluripotent stem cells.</gtr:title><gtr:parentPublicationTitle>Cell death &amp; disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf6dbcc7eab91ddd02d8dafa51460879"><gtr:id>bf6dbcc7eab91ddd02d8dafa51460879</gtr:id><gtr:otherNames>Grespi F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58c6cdfe0a12a1.83915895</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5FC19EB7-CE66-4F53-8E1D-BFEE94B8B694</gtr:id><gtr:title>PIR2/Rnf144B regulates epithelial homeostasis by mediating degradation of p21WAF1 and p63.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a5bce11b4bbb7a8c4c5cc2bb1c719551"><gtr:id>a5bce11b4bbb7a8c4c5cc2bb1c719551</gtr:id><gtr:otherNames>Conforti F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>pm_12587_27_23128396</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>30661E92-A08E-4BB1-AF85-795B923005CF</gtr:id><gtr:title>FLASH is required for histone transcription and S-phase progression.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9a2cd7869fab1403870cb05824b98470"><gtr:id>9a2cd7869fab1403870cb05824b98470</gtr:id><gtr:otherNames>Barcaroli D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>C28F8FB7590</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>40304712-F46F-479E-B95B-1B20480138F6</gtr:id><gtr:title>ITCH deficiency protects from diet-induced obesity.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1712158953fdf21aae3e877a19789453"><gtr:id>1712158953fdf21aae3e877a19789453</gtr:id><gtr:otherNames>Marino A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn><gtr:outcomeId>pm_12587_27_24170694</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>33307A10-14F3-40BD-B451-09203701DD56</gtr:id><gtr:title>TAp73 regulates the spindle assembly checkpoint by modulating BubR1 activity.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad49b2228bb35fb6073bb749ba051fd7"><gtr:id>ad49b2228bb35fb6073bb749ba051fd7</gtr:id><gtr:otherNames>Tomasini R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>CC9F857223D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>77254B8F-1A1F-4524-A44A-8A9995E48C9A</gtr:id><gtr:title>The p63 target HBP1 is required for skin differentiation and stratification.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/997642a182964076367ee779ef7386c7"><gtr:id>997642a182964076367ee779ef7386c7</gtr:id><gtr:otherNames>Borrelli S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>X8CatodztcD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1C979218-BD0D-4D8A-915C-ACD82AD1A458</gtr:id><gtr:title>The F-box protein FBXO45 promotes the proteasome-dependent degradation of p73.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9e4119986f75688fbc0aed5020f48894"><gtr:id>9e4119986f75688fbc0aed5020f48894</gtr:id><gtr:otherNames>Peschiaroli A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>18C44C46C0A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D4FED9AE-CEA5-4581-8617-CC7CBC9C51E5</gtr:id><gtr:title>Cell death pathology: the war against cancer.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d22fc1f6855fc0c192fe4e566ef0a2bd"><gtr:id>d22fc1f6855fc0c192fe4e566ef0a2bd</gtr:id><gtr:otherNames>Rufini A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn><gtr:outcomeId>XGVJEowA2jF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4CF43596-191C-4C99-933C-3ABC4B8613A6</gtr:id><gtr:title>FLASH is essential during early embryogenesis and cooperates with p73 to regulate histone gene transcription.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ae10a0d8cc464203807bc56eefe699cb"><gtr:id>ae10a0d8cc464203807bc56eefe699cb</gtr:id><gtr:otherNames>De Cola A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>BcFa4xafXC2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1419B521-5A79-4455-B51D-E73CCAB644E6</gtr:id><gtr:title>Cell death in disease: from 2010 onwards.</gtr:title><gtr:parentPublicationTitle>Cell death &amp; disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bc92fafe95c6ea9d7e35409b3c85a70"><gtr:id>2bc92fafe95c6ea9d7e35409b3c85a70</gtr:id><gtr:otherNames>Knight RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>fT1Bz64G1oM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D6C6FF50-9EBA-49C6-B039-7B5C831118E7</gtr:id><gtr:title>Lysine-specific modifications of p53: a matter of life and death?</gtr:title><gtr:parentPublicationTitle>Oncotarget</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac71a071643527f94a8351cdddac7f65"><gtr:id>ac71a071643527f94a8351cdddac7f65</gtr:id><gtr:otherNames>Marouco D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1949-2553</gtr:issn><gtr:outcomeId>545fa7403290a4.13105022</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C2A27F43-FF72-4027-A325-892E2E47E7F9</gtr:id><gtr:title>ZNF281 contributes to the DNA damage response by controlling the expression of XRCC2 and XRCC4.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ffdd89ae07415943d2b13fc500f29bf6"><gtr:id>ffdd89ae07415943d2b13fc500f29bf6</gtr:id><gtr:otherNames>Pieraccioli M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>56cb40e4c69ab2.37940315</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5952B599-0511-41F6-B927-550FA19EDBEC</gtr:id><gtr:title>The emerging role of Notch pathway in ageing: Focus on the related mechanisms in age-related diseases.</gtr:title><gtr:parentPublicationTitle>Ageing research reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4f9500221e2dda3a91384d8b308342f"><gtr:id>a4f9500221e2dda3a91384d8b308342f</gtr:id><gtr:otherNames>Balistreri CR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1568-1637</gtr:issn><gtr:outcomeId>58c6cdff10eff5.07765551</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>19864071-B61C-469D-AAE2-262E494AB2C4</gtr:id><gtr:title>Activation of miR200 by c-Myb depends on ZEB1 expression and miR200 promoter methylation.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ffdd89ae07415943d2b13fc500f29bf6"><gtr:id>ffdd89ae07415943d2b13fc500f29bf6</gtr:id><gtr:otherNames>Pieraccioli M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>pm_12587_27_24067373</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CA624B7F-60EE-4F83-B550-7BB2D0283573</gtr:id><gtr:title>TAp73 knockout mice show morphological and functional nervous system defects associated with loss of p75 neurotrophin receptor.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b21c3c9674658143d31f9840ad2861f9"><gtr:id>b21c3c9674658143d31f9840ad2861f9</gtr:id><gtr:otherNames>Niklison-Chirou MV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_12587_27_24190996</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B691356B-B87F-47D6-BB2B-94277EAFAF90</gtr:id><gtr:title>TAp73 depletion accelerates aging through metabolic dysregulation.</gtr:title><gtr:parentPublicationTitle>Genes &amp; development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d22fc1f6855fc0c192fe4e566ef0a2bd"><gtr:id>d22fc1f6855fc0c192fe4e566ef0a2bd</gtr:id><gtr:otherNames>Rufini A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0890-9369</gtr:issn><gtr:outcomeId>pm_12587_27_22987635</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B2C1EE85-C927-416E-9577-87C9EFC40B8C</gtr:id><gtr:title>STAT1 regulates p73-mediated Bax gene expression.</gtr:title><gtr:parentPublicationTitle>FEBS letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/16e0ae7f5b742a76adaacf5f51cf9f3e"><gtr:id>16e0ae7f5b742a76adaacf5f51cf9f3e</gtr:id><gtr:otherNames>Soond SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0014-5793</gtr:issn><gtr:outcomeId>CFC70D3DA6C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7230015B-CD3B-45F8-B1C7-0F81DBFDAC37</gtr:id><gtr:title>P53 functional abnormality in mesenchymal stem cells promotes osteosarcoma development.</gtr:title><gtr:parentPublicationTitle>Cell death &amp; disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f5b57a824c7e5fe82a148ee56800f03"><gtr:id>4f5b57a824c7e5fe82a148ee56800f03</gtr:id><gtr:otherNames>Velletri T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58c6ced350c890.87279466</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B421D25-9D36-4DF1-8491-FE66D0E85723</gtr:id><gtr:title>Anti-oxidative stress response genes: bioinformatic analysis of their expression and relevance in multiple cancers.</gtr:title><gtr:parentPublicationTitle>Oncotarget</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/15f15e5a26ebf9d19327bfe518516dd0"><gtr:id>15f15e5a26ebf9d19327bfe518516dd0</gtr:id><gtr:otherNames>Rotblat B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1949-2553</gtr:issn><gtr:outcomeId>545fa7408054a4.47941655</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41B2612A-145F-4904-B1B3-2D834B661776</gtr:id><gtr:title>The hypoxic tumour microenvironment.</gtr:title><gtr:parentPublicationTitle>Oncogenesis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fff520da2fc64fe158aaf80324336983"><gtr:id>fff520da2fc64fe158aaf80324336983</gtr:id><gtr:otherNames>Petrova V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>2157-9024</gtr:issn><gtr:outcomeId>5aaa6664cc3168.34621494</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C8F28580-A7EC-4A5E-BD83-0B8C6D38FC25</gtr:id><gtr:title>Transglutaminase 2--a novel inhibitor of adipogenesis.</gtr:title><gtr:parentPublicationTitle>Cell death &amp; disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/070a9721f28eb1848736188e3158c7c0"><gtr:id>070a9721f28eb1848736188e3158c7c0</gtr:id><gtr:otherNames>Myneni VD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56cb40e46a7f69.00390758</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>44FD7E4F-8067-4B2D-993C-2868B5BF59DE</gtr:id><gtr:title>p63 regulates glutaminase 2 expression.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/361ef09d10b05604c4d390ab5dea3ca3"><gtr:id>361ef09d10b05604c4d390ab5dea3ca3</gtr:id><gtr:otherNames>Giacobbe A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>pm_12587_27_23574722</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>30530216-702B-49C7-BFD7-1A598A3F5EB0</gtr:id><gtr:title>Screening for E3-ubiquitin ligase inhibitors: challenges and opportunities.</gtr:title><gtr:parentPublicationTitle>Oncotarget</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f21b0e2068cc66ca298b73771eefe30"><gtr:id>1f21b0e2068cc66ca298b73771eefe30</gtr:id><gtr:otherNames>Landr? V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1949-2553</gtr:issn><gtr:outcomeId>545fa6f43d0634.78270245</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DCA78208-B2E0-4A09-8FD9-B1FE529A6869</gtr:id><gtr:title>Netrin-1 induces apoptosis in human cervical tumor cells via the TAp73alpha tumor suppressor.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/06a88d9caada0dbd061b8fd8c944cd62"><gtr:id>06a88d9caada0dbd061b8fd8c944cd62</gtr:id><gtr:otherNames>Roperch JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>BE57989FBE5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FCF6BD37-EA1A-4DAE-B122-A58BAE183138</gtr:id><gtr:title>?Np73? is oncogenic in hepatocellular carcinoma by blocking apoptosis signaling via death receptors and mitochondria.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/11a4a878d1189f59e0d210b81239bd35"><gtr:id>11a4a878d1189f59e0d210b81239bd35</gtr:id><gtr:otherNames>Schuster A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>k1PG44b9ijo</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B2387350-D0D0-40C5-AE00-04500DF0CBFB</gtr:id><gtr:title>miR-24 affects hair follicle morphogenesis targeting Tcf-3.</gtr:title><gtr:parentPublicationTitle>Cell death &amp; disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8202ec23ce7877b2a6c8080563ce1fe"><gtr:id>f8202ec23ce7877b2a6c8080563ce1fe</gtr:id><gtr:otherNames>Amelio I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>545fa74007f421.50244097</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9D96B042-0444-467E-8063-CA0958F91431</gtr:id><gtr:title>Desmethylclomipramine induces the accumulation of autophagy markers by blocking autophagic flux.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5ee5a13f7d6b0787d4919dd19ba893a"><gtr:id>c5ee5a13f7d6b0787d4919dd19ba893a</gtr:id><gtr:otherNames>Rossi M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>5E9D1A59BE6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BE1871B3-6B93-4AE9-9F18-569F339DA0FB</gtr:id><gtr:title>p73 regulates basal and starvation-induced liver metabolism in vivo.</gtr:title><gtr:parentPublicationTitle>Oncotarget</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b03f035e73466bcfdbad2cfe3bcc7556"><gtr:id>b03f035e73466bcfdbad2cfe3bcc7556</gtr:id><gtr:otherNames>He Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1949-2553</gtr:issn><gtr:outcomeId>56cb40e1dd8651.85989548</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3562B6C6-E038-4BC5-BC86-AB53B4931C52</gtr:id><gtr:title>p73 regulates autophagy and hepatocellular lipid metabolism through a transcriptional activation of the ATG5 gene.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b03f035e73466bcfdbad2cfe3bcc7556"><gtr:id>b03f035e73466bcfdbad2cfe3bcc7556</gtr:id><gtr:otherNames>He Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>pm_12587_27_23912709</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF574575-425A-433A-B7D6-DC881EAA4892</gtr:id><gtr:title>p63 regulates the caspase-8-FLIP apoptotic pathway in epidermis.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/997642a182964076367ee779ef7386c7"><gtr:id>997642a182964076367ee779ef7386c7</gtr:id><gtr:otherNames>Borrelli S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>8011D9311C8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BEE38D9D-6608-4D3E-A182-084ABF878D66</gtr:id><gtr:title>Discovery of Novel Isatin-Based p53 Inducers.</gtr:title><gtr:parentPublicationTitle>ACS medicinal chemistry letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/37b1b9f0d2bc2a0a6482ff2b0e09af76"><gtr:id>37b1b9f0d2bc2a0a6482ff2b0e09af76</gtr:id><gtr:otherNames>Davidovich P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1948-5875</gtr:issn><gtr:outcomeId>56cb40e4f1f5f7.73472429</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DA182137-2815-4D99-9217-4B7555667748</gtr:id><gtr:title>ITCH modulates SIRT6 and SREBP2 to influence lipid metabolism and atherosclerosis in ApoE null mice.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c1fbb7b6a70c57a0f073e21bc1b27c35"><gtr:id>c1fbb7b6a70c57a0f073e21bc1b27c35</gtr:id><gtr:otherNames>St?hr R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>56cb40e8031da9.86373901</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C68D007E-E4AF-44B2-B0CA-6CF35E0C1489</gtr:id><gtr:title>MicroRNAs, miR-154, miR-299-5p, miR-376a, miR-376c, miR-377, miR-381, miR-487b, miR-485-3p, miR-495 and miR-654-3p, mapped to the 14q32.31 locus, regulate proliferation, apoptosis, migration and invasion in metastatic prostate cancer cells.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/09c0f58673cbe7af98774f2addbf8e73"><gtr:id>09c0f58673cbe7af98774f2addbf8e73</gtr:id><gtr:otherNames>Formosa A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>pm_12587_27_24166498</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F65297FD-C818-44DF-9B62-1FA8CD4184EE</gtr:id><gtr:title>[Vincenzo Cuomo, health officer and general practitioner on the Isle of Capri].</gtr:title><gtr:parentPublicationTitle>Annali di igiene : medicina preventiva e di comunita</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d8e8a9316c7daaaa66fa9552e525b91a"><gtr:id>d8e8a9316c7daaaa66fa9552e525b91a</gtr:id><gtr:otherNames>Melino C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1120-9135</gtr:issn><gtr:outcomeId>gHHVumSJwqw</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B2A73174-191F-4F25-8937-F05B7E47E112</gtr:id><gtr:title>Luteolin-7-glucoside inhibits IL-22/STAT3 pathway, reducing proliferation, acanthosis, and inflammation in keratinocytes and in mouse psoriatic model.</gtr:title><gtr:parentPublicationTitle>Cell death &amp; disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3081b0b8581f7e474fc4d6d4974c35a6"><gtr:id>3081b0b8581f7e474fc4d6d4974c35a6</gtr:id><gtr:otherNames>Palombo R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58c6cdfe915b45.69061399</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>390247C3-C1AE-4D8E-B7A2-CA74F5A13CB8</gtr:id><gtr:title>Blockade of Stearoyl-CoA-desaturase 1 activity reverts resistance to cisplatin in lung cancer stem cells.</gtr:title><gtr:parentPublicationTitle>Cancer letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/005f5a4767d39d3e8f7dac887c2500de"><gtr:id>005f5a4767d39d3e8f7dac887c2500de</gtr:id><gtr:otherNames>Pisanu ME</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0304-3835</gtr:issn><gtr:outcomeId>5aaa666475e0c2.10575971</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CCDB8588-B4A9-47A4-8A08-E20F0CB2F7DD</gtr:id><gtr:title>Oxidative stress activation of miR-125b is part of the molecular switch for Hailey-Hailey disease manifestation.</gtr:title><gtr:parentPublicationTitle>Experimental dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1c7c01af965de7a2d102ecbb7f99bb4"><gtr:id>e1c7c01af965de7a2d102ecbb7f99bb4</gtr:id><gtr:otherNames>Manca S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0906-6705</gtr:issn><gtr:outcomeId>BoYZk1HuUwR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5BCBD2D1-6A80-442A-A335-EB8628C2E9D6</gtr:id><gtr:title>The E3 ubiquitin ligase WWP1 sustains the growth of acute myeloid leukaemia.</gtr:title><gtr:parentPublicationTitle>Leukemia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c46d9f7795469bbb48b4d875d6e31b0"><gtr:id>3c46d9f7795469bbb48b4d875d6e31b0</gtr:id><gtr:otherNames>Sanarico AG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0887-6924</gtr:issn><gtr:outcomeId>5aaa666543b5e0.49257559</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ABE1AC18-2CB9-4B74-8F1A-477D701288E3</gtr:id><gtr:title>The interaction of heparan sulfate proteoglycans with endothelial transglutaminase-2 limits VEGF165-induced angiogenesis.</gtr:title><gtr:parentPublicationTitle>Science signaling</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d37c6566b956d6d108fb7cceca1865fc"><gtr:id>d37c6566b956d6d108fb7cceca1865fc</gtr:id><gtr:otherNames>Beckouche N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1945-0877</gtr:issn><gtr:outcomeId>56cb40e64075a0.85954824</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6C540847-3FF4-4EE7-8B59-D1BB8C082C27</gtr:id><gtr:title>MicroRNAs in human skin ageing.</gtr:title><gtr:parentPublicationTitle>Ageing research reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d4dfbc5f3f72a159e19a1e181ef4e64c"><gtr:id>d4dfbc5f3f72a159e19a1e181ef4e64c</gtr:id><gtr:otherNames>Mancini M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1568-1637</gtr:issn><gtr:outcomeId>545fa6f3449186.01972558</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>09811518-9920-43E7-A39D-A2106983F636</gtr:id><gtr:title>The 26S proteasome is a multifaceted target for anti-cancer therapies.</gtr:title><gtr:parentPublicationTitle>Oncotarget</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2665b33b31ff39b3d1f95d48ff793eb2"><gtr:id>2665b33b31ff39b3d1f95d48ff793eb2</gtr:id><gtr:otherNames>Grigoreva TA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1949-2553</gtr:issn><gtr:outcomeId>56cb40e38819c0.11316235</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3CF208F0-C9B3-4F8F-AA35-862E44DE2682</gtr:id><gtr:title>Inhibition of the c-Abl-TAp63 pathway protects mouse oocytes from chemotherapy-induced death.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/76d69c98b7f819c3c3a6aad6e1fe99cb"><gtr:id>76d69c98b7f819c3c3a6aad6e1fe99cb</gtr:id><gtr:otherNames>Gonfloni S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn><gtr:outcomeId>9039F835FB4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FC8B3554-DBBA-40D6-B565-9D60DD393858</gtr:id><gtr:title>MicroRNA-203 contributes to skin re-epithelialization.</gtr:title><gtr:parentPublicationTitle>Cell death &amp; disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e031c271351b66689cde41b23e8e02ba"><gtr:id>e031c271351b66689cde41b23e8e02ba</gtr:id><gtr:otherNames>Viticchi? G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>pm_12587_27_23190607</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>951BD7A8-9421-49DD-B9A3-249CB2FC0DAA</gtr:id><gtr:title>The Nedd4-binding partner 1 (N4BP1) protein is an inhibitor of the E3 ligase Itch.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/55be65089c51411de3ae51712e7d01e8"><gtr:id>55be65089c51411de3ae51712e7d01e8</gtr:id><gtr:otherNames>Oberst A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>9E1680C0E19</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>36257EB2-70D4-400A-8C28-8091C2577592</gtr:id><gtr:title>p63 is upstream of IKK alpha in epidermal development.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf02bfffc596a84b2aa376016aa486ba"><gtr:id>cf02bfffc596a84b2aa376016aa486ba</gtr:id><gtr:otherNames>Candi E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>34A59ED31E2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A869105-E561-4D15-86BE-A6876E3588A4</gtr:id><gtr:title>DNA repair and aging: the impact of the p53 family.</gtr:title><gtr:parentPublicationTitle>Aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/370225cfc75977d43980762e8cd70a1a"><gtr:id>370225cfc75977d43980762e8cd70a1a</gtr:id><gtr:otherNames>Nicolai S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1945-4589</gtr:issn><gtr:outcomeId>56cb40e0933256.27930104</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B0EBA82-ECBA-4530-A918-F77644E8756E</gtr:id><gtr:title>Allele-specific silencing of EEC p63 mutant R304W restores p63 transcriptional activity.</gtr:title><gtr:parentPublicationTitle>Cell death &amp; disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f213eaade9663c7369a488e5aa1b3e4"><gtr:id>9f213eaade9663c7369a488e5aa1b3e4</gtr:id><gtr:otherNames>Novelli F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58c6ce00919507.34878068</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>969A71CD-647F-4DC8-B2A7-782E2604A864</gtr:id><gtr:title>How the TP53 family proteins TP63 and TP73 contribute to tumorigenesis: regulators and effectors.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf02bfffc596a84b2aa376016aa486ba"><gtr:id>cf02bfffc596a84b2aa376016aa486ba</gtr:id><gtr:otherNames>Candi E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>545fa6f22b7141.22792889</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>176B27E5-FEF4-4133-A611-BAD8F618B736</gtr:id><gtr:title>TAp73 transcriptionally represses BNIP3 expression.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fff520da2fc64fe158aaf80324336983"><gtr:id>fff520da2fc64fe158aaf80324336983</gtr:id><gtr:otherNames>Petrova V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>56cb40e57a8b79.18074387</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F1BFF924-5CC0-4CFF-85F8-924C7C19C40F</gtr:id><gtr:title>The Cul4A-DDB1 E3 ubiquitin ligase complex represses p73 transcriptional activity.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/57c1b4b2906aa90caab84153883a7a46"><gtr:id>57c1b4b2906aa90caab84153883a7a46</gtr:id><gtr:otherNames>Malatesta M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>pm_12587_27_23085759</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>29433810-DCC2-437C-A52C-8A5B9A9871F6</gtr:id><gtr:title>The HECT family of E3 ubiquitin ligases: multiple players in cancer development.</gtr:title><gtr:parentPublicationTitle>Cancer cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7876abe36dc197edd850bcd158433472"><gtr:id>7876abe36dc197edd850bcd158433472</gtr:id><gtr:otherNames>Bernassola F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1535-6108</gtr:issn><gtr:outcomeId>A328EFE7F0E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>183D79FA-20CF-43C4-B4C2-0908253D2B93</gtr:id><gtr:title>TGFbeta mediates activation of transglutaminase 2 in response to oxidative stress that leads to protein aggregation.</gtr:title><gtr:parentPublicationTitle>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/852ee852f33deeb7e4ebbbf0b7193d64"><gtr:id>852ee852f33deeb7e4ebbbf0b7193d64</gtr:id><gtr:otherNames>Shin DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn><gtr:outcomeId>706DDE5B4ED</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1DD79F02-7974-4961-8941-C23019E74310</gtr:id><gtr:title>p63 transcriptionally regulates the expression of matrix metallopeptidase 13.</gtr:title><gtr:parentPublicationTitle>Oncotarget</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2cd5d10f841c27e2f13c2b8f63b6c177"><gtr:id>2cd5d10f841c27e2f13c2b8f63b6c177</gtr:id><gtr:otherNames>Celardo I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1949-2553</gtr:issn><gtr:outcomeId>545fa6f2eb3872.87202570</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6890C565-0376-494E-8503-49F0104A900C</gtr:id><gtr:title>TAp73 knockout shows genomic instability with infertility and tumor suppressor functions.</gtr:title><gtr:parentPublicationTitle>Genes &amp; development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad49b2228bb35fb6073bb749ba051fd7"><gtr:id>ad49b2228bb35fb6073bb749ba051fd7</gtr:id><gtr:otherNames>Tomasini R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0890-9369</gtr:issn><gtr:outcomeId>2F412D2318C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B0A3CF2F-F882-4E3F-8C1D-772FF02E4DB0</gtr:id><gtr:title>FLASH and NPAT positive but not Coilin positive Cajal Bodies correlate with cell ploidy.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b84cef5ab4776b4fa1c823b470fe7fc"><gtr:id>7b84cef5ab4776b4fa1c823b470fe7fc</gtr:id><gtr:otherNames>Bongiorno-Borbone L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>AC245842B22</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DB1C554A-B0A6-4E9A-9B7E-5570E1589294</gtr:id><gtr:title>Caloric restriction: is mammalian life extension linked to p53?</gtr:title><gtr:parentPublicationTitle>Aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/11b8def079cf2505dd3d25563d4fcb61"><gtr:id>11b8def079cf2505dd3d25563d4fcb61</gtr:id><gtr:otherNames>Tucci P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1945-4589</gtr:issn><gtr:outcomeId>pm_12587_27_22983298</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C27BEE59-52F1-4B8D-903A-B5C7773EFF50</gtr:id><gtr:title>TAp73 isoforms antagonize Notch signalling in SH-SY5Y neuroblastomas and in primary neurones.</gtr:title><gtr:parentPublicationTitle>Journal of neurochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4215c217848c45eaa4c6f947d1263ba9"><gtr:id>4215c217848c45eaa4c6f947d1263ba9</gtr:id><gtr:otherNames>Hooper C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn><gtr:outcomeId>C2F0917D626</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B0E3F66D-57D8-4A29-B9D0-4C47789CBF66</gtr:id><gtr:title>The antiapoptotic DeltaNp73 is degraded in a c-Jun-dependent manner upon genotoxic stress through the antizyme-mediated pathway.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6cf8e883d495bc09e8ac73ac6b416cd8"><gtr:id>6cf8e883d495bc09e8ac73ac6b416cd8</gtr:id><gtr:otherNames>Dulloo I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>o853kfwWWba</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>82C8D78F-B8D9-4540-8F84-867C2E1A8E62</gtr:id><gtr:title>One, two, three--p53, p63, p73 and chemosensitivity.</gtr:title><gtr:parentPublicationTitle>Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/801e60f22e59f3743776586107b7098b"><gtr:id>801e60f22e59f3743776586107b7098b</gtr:id><gtr:otherNames>M?ller M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1368-7646</gtr:issn><gtr:outcomeId>EB8345A5F5A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E313FFE0-C129-4D64-99CF-12995998462C</gtr:id><gtr:title>p73 and p63 regulate the expression of fibroblast growth factor receptor 3.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/532598b98b028a69feb3aaf7c4089099"><gtr:id>532598b98b028a69feb3aaf7c4089099</gtr:id><gtr:otherNames>Sayan AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn><gtr:outcomeId>BwAjWuC1cxF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8A4573D7-E7B5-40EE-BCEE-9107BCBD8B53</gtr:id><gtr:title>Dominant negative (DeltaN) p63alpha induces drug resistance in hepatocellular carcinoma by interference with apoptosis signaling pathways.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fcaabbe367e7324f16868f67824051bf"><gtr:id>fcaabbe367e7324f16868f67824051bf</gtr:id><gtr:otherNames>Mundt HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn><gtr:outcomeId>mkdzB8zsgkn</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F9D1CE79-B3D2-4D2D-8AB5-F1BA19BA37F6</gtr:id><gtr:title>Antidepressants synergize with chemotherapy against cancer stem cells.</gtr:title><gtr:parentPublicationTitle>Aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/15a25fc8d85639e9e4f6c3b56a2a6100"><gtr:id>15a25fc8d85639e9e4f6c3b56a2a6100</gtr:id><gtr:otherNames>Melino G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1945-4589</gtr:issn><gtr:outcomeId>56cb40e0dbf635.70738046</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C37D5CDC-45C5-4AEB-9BF1-36B158A49C90</gtr:id><gtr:title>Brn-3a/POU4F1 interacts with and differentially affects p73-mediated transcription.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2917f149fdc886325e1086b99a28b5c6"><gtr:id>2917f149fdc886325e1086b99a28b5c6</gtr:id><gtr:otherNames>Hudson CD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>0C14A21A418</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>65F5A56B-DEAC-4901-A230-9516BF2D3F0F</gtr:id><gtr:title>Fog of war: the emerging p53 family.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f2eac978f63b01e60778811026f3066b"><gtr:id>f2eac978f63b01e60778811026f3066b</gtr:id><gtr:otherNames>McKeon F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>9D95E07893D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>855B996E-33ED-41A6-ACCF-77F72FA36EE5</gtr:id><gtr:title>Identification of transglutaminase 3 splicing isoforms.</gtr:title><gtr:parentPublicationTitle>The Journal of investigative dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7f6b482a55caf5f3215dac6e0f40b06f"><gtr:id>7f6b482a55caf5f3215dac6e0f40b06f</gtr:id><gtr:otherNames>Zocchi L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-202X</gtr:issn><gtr:outcomeId>4F0B886C69F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>055632E7-A361-49A6-A354-99BD0F404F39</gtr:id><gtr:title>Transglutaminase 2 interactions with extracellular matrix proteins as probed with celiac disease autoantibodies.</gtr:title><gtr:parentPublicationTitle>The FEBS journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2e3f424ff815ef2fe587758aed578099"><gtr:id>2e3f424ff815ef2fe587758aed578099</gtr:id><gtr:otherNames>Cardoso I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1742-464X</gtr:issn><gtr:outcomeId>56cb40e70bba54.24609225</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AB229A50-32E9-4C83-9F4D-3E692C393CB2</gtr:id><gtr:title>Specific isoforms of p73 control the induction of cell death induced by the viral proteins, E1A or apoptin.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a6d65294e81ceb791ff78c3899b18522"><gtr:id>a6d65294e81ceb791ff78c3899b18522</gtr:id><gtr:otherNames>Klanrit P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>D81F2B958FE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B05C7C6-6F66-44FD-A76A-5E0EDBCB26D4</gtr:id><gtr:title>?Np63 is an ectodermal gatekeeper of epidermal morphogenesis.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/257bd288ab6da1119125f1d1528660da"><gtr:id>257bd288ab6da1119125f1d1528660da</gtr:id><gtr:otherNames>Shalom-Feuerstein R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>siXnqxKLddU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F692BFAE-2969-4409-8FA3-FD5FCB3C225A</gtr:id><gtr:title>Transglutaminase-2 differently regulates cartilage destruction and osteophyte formation in a surgical model of osteoarthritis.</gtr:title><gtr:parentPublicationTitle>Amino acids</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5da092a96ef722064e43ac8fec8da91b"><gtr:id>5da092a96ef722064e43ac8fec8da91b</gtr:id><gtr:otherNames>Orlandi A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0939-4451</gtr:issn><gtr:outcomeId>DC35484292F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B38B46A1-9662-4A98-8E34-CA5FEAEB8B46</gtr:id><gtr:title>FLASH degradation in response to UV-C results in histone locus bodies disruption and cell-cycle arrest.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b84cef5ab4776b4fa1c823b470fe7fc"><gtr:id>7b84cef5ab4776b4fa1c823b470fe7fc</gtr:id><gtr:otherNames>Bongiorno-Borbone L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>21D8CB7EE29</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B02339B-3866-429F-971B-4D8AD3F5C377</gtr:id><gtr:title>The interplay between inflammation and metabolism in rheumatoid arthritis.</gtr:title><gtr:parentPublicationTitle>Cell death &amp; disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1fa8c3198b4789ca282cbe620271dfde"><gtr:id>1fa8c3198b4789ca282cbe620271dfde</gtr:id><gtr:otherNames>Chimenti MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56cb40e3bab089.21251793</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>91DA6572-8155-42EF-ABE9-1C893B6B6774</gtr:id><gtr:title>Cytoplasmic function of mutant promyelocytic leukemia (PML) and PML-retinoic acid receptor-alpha.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a1448bee0ae56bd58fecff6db43339f5"><gtr:id>a1448bee0ae56bd58fecff6db43339f5</gtr:id><gtr:otherNames>Bellodi C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>D13E8A2C151</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4C859F67-6D03-4369-A822-2D6CABC828B3</gtr:id><gtr:title>p63 in epithelial development.</gtr:title><gtr:parentPublicationTitle>Cellular and molecular life sciences : CMLS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf02bfffc596a84b2aa376016aa486ba"><gtr:id>cf02bfffc596a84b2aa376016aa486ba</gtr:id><gtr:otherNames>Candi E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1420-682X</gtr:issn><gtr:outcomeId>A1993E8574B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF612EFD-463B-44E3-A63E-402C3CD37CE7</gtr:id><gtr:title>New factors in mammalian DNA repair-the chromatin connection.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4e144e85f6b35b0b47ad70427c196bab"><gtr:id>4e144e85f6b35b0b47ad70427c196bab</gtr:id><gtr:otherNames>Raschell? G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>5aaa670ef2df59.53311858</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F56BB47B-78D3-4222-8A4D-61399338CA7D</gtr:id><gtr:title>The p53 tetramer shows an induced-fit interaction of the C-terminal domain with the DNA-binding domain.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fcb61412752c4685d7119cf17a1810c6"><gtr:id>fcb61412752c4685d7119cf17a1810c6</gtr:id><gtr:otherNames>D'Abramo M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>56cb40e22457d0.22255690</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A8D159EA-A069-4F5B-A534-B017C3C9378C</gtr:id><gtr:title>DeltaNp63 regulates thymic development through enhanced expression of FgfR2 and Jag2.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf02bfffc596a84b2aa376016aa486ba"><gtr:id>cf02bfffc596a84b2aa376016aa486ba</gtr:id><gtr:otherNames>Candi E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>55081B1E8CF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1673B777-BC6D-4D60-905F-93144717DF93</gtr:id><gtr:title>Increased Sympathetic Renal Innervation in Hemodialysis Patients Is the Anatomical Substrate of Sympathetic Hyperactivity in End-Stage Renal Disease.</gtr:title><gtr:parentPublicationTitle>Journal of the American Heart Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ee713da9c7887a2e927880b456cf48a6"><gtr:id>ee713da9c7887a2e927880b456cf48a6</gtr:id><gtr:otherNames>Mauriello A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2047-9980</gtr:issn><gtr:outcomeId>56cb40e14a76c5.87816928</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>56046261-3B9F-46AA-B969-C34D283FB633</gtr:id><gtr:title>TAp73alpha binds the kinetochore proteins Bub1 and Bub3 resulting in polyploidy.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0ddd07bdbd15c9f5ba18a9facf269896"><gtr:id>0ddd07bdbd15c9f5ba18a9facf269896</gtr:id><gtr:otherNames>Vernole P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>D1FA7937F30</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF3E98C3-C467-47B9-AD0A-62F0E513629E</gtr:id><gtr:title>?Np63-mediated regulation of hyaluronic acid metabolism and signaling supports HNSCC tumorigenesis.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c93bd3e09de4b6ca407cc7a8985e6b18"><gtr:id>c93bd3e09de4b6ca407cc7a8985e6b18</gtr:id><gtr:otherNames>Compagnone M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>5aaa6665658988.96096749</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F15FE647-1F27-485C-B946-77AD6D05CBAF</gtr:id><gtr:title>Metabolic profiling of human CD4+ cells following treatment with methotrexate and anti-TNF-a infliximab.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1fa8c3198b4789ca282cbe620271dfde"><gtr:id>1fa8c3198b4789ca282cbe620271dfde</gtr:id><gtr:otherNames>Chimenti MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>pm_12587_27_23974102</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>499122E4-626C-467D-BD4B-0E166E1C1A1A</gtr:id><gtr:title>p63 protein is essential for the embryonic development of vibrissae and teeth.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d22fc1f6855fc0c192fe4e566ef0a2bd"><gtr:id>d22fc1f6855fc0c192fe4e566ef0a2bd</gtr:id><gtr:otherNames>Rufini A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn><gtr:outcomeId>97B06828106</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D55EE196-49CC-46FB-ABA5-2B23D4B401C5</gtr:id><gtr:title>Hypertension in kidney transplantation is associated with an early renal nerve sprouting.</gtr:title><gtr:parentPublicationTitle>Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ee713da9c7887a2e927880b456cf48a6"><gtr:id>ee713da9c7887a2e927880b456cf48a6</gtr:id><gtr:otherNames>Mauriello A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0931-0509</gtr:issn><gtr:outcomeId>5aaa6666eab913.44023648</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>00E4F9AB-F8F7-4E37-838D-9854938050A5</gtr:id><gtr:title>&amp;quot;Tissue&amp;quot; transglutaminase contributes to the formation of disulphide bridges in proteins of mitochondrial respiratory complexes.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2902204218d7ea9b8478f73e4f6c2b99"><gtr:id>2902204218d7ea9b8478f73e4f6c2b99</gtr:id><gtr:otherNames>Mastroberardino PG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>8AF578FD1DE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B765444D-9B68-488A-BA07-EC6B7D110CEC</gtr:id><gtr:title>Polypharmacology of small molecules targeting the ubiquitin-proteasome and ubiquitin-like systems.</gtr:title><gtr:parentPublicationTitle>Oncotarget</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8202ec23ce7877b2a6c8080563ce1fe"><gtr:id>f8202ec23ce7877b2a6c8080563ce1fe</gtr:id><gtr:otherNames>Amelio I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1949-2553</gtr:issn><gtr:outcomeId>56cb40e76c36f2.12988761</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0ECAF69E-9C07-4B80-89D7-0ED6F9958403</gtr:id><gtr:title>Amino-terminal residues of ?Np63, mutated in ectodermal dysplasia, are required for its transcriptional activity.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8cb8d55f2ed73e9941c053cd7fb914e2"><gtr:id>8cb8d55f2ed73e9941c053cd7fb914e2</gtr:id><gtr:otherNames>Lena AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn><gtr:outcomeId>56cb40e173fe27.23253349</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0CD28F97-C501-4875-91A5-95079BF61794</gtr:id><gtr:title>Itch inhibition regulates chemosensitivity in vitro.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52713e6c6dffb34f3763120316f5e53f"><gtr:id>52713e6c6dffb34f3763120316f5e53f</gtr:id><gtr:otherNames>Hansen TM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn><gtr:outcomeId>1A1A48753D6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B21A6EA-71FD-4EED-9C14-D7E643D4DD35</gtr:id><gtr:title>Transglutaminase-dependent RhoA activation and depletion by serotonin in vascular smooth muscle cells.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c9e5c1ade93015ac3eb2e889497aa8e3"><gtr:id>c9e5c1ade93015ac3eb2e889497aa8e3</gtr:id><gtr:otherNames>Guilluy C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>A578685E2F4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CCD7DB35-D11A-4AF3-8617-A21AABC1F01D</gtr:id><gtr:title>Epithelial transglutaminase 2 is needed for T cell interleukin-17 production and subsequent pulmonary inflammation and fibrosis in bleomycin-treated mice.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2e5dbd65d6675bd60473c339562cf798"><gtr:id>2e5dbd65d6675bd60473c339562cf798</gtr:id><gtr:otherNames>Oh K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>UPHZfYc2TX9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>24FF257B-70DF-4845-957A-DC4C24681C11</gtr:id><gtr:title>The anti-HER3 (ErbB3) therapeutic antibody 9F7-F11 induces HER3 ubiquitination and degradation in tumors through JNK1/2- dependent ITCH/AIP4 activation.</gtr:title><gtr:parentPublicationTitle>Oncotarget</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ed802cd2408bb3414c7f7a7cc2cec78c"><gtr:id>ed802cd2408bb3414c7f7a7cc2cec78c</gtr:id><gtr:otherNames>Le Clorennec C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1949-2553</gtr:issn><gtr:outcomeId>58c6cdffdff599.62774479</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6BEB59F5-54BD-4A07-900B-EC9A63991597</gtr:id><gtr:title>p63 and p73, the ancestors of p53.</gtr:title><gtr:parentPublicationTitle>Cold Spring Harbor perspectives in biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e7c8e6eb292ef515be8d56030897f123"><gtr:id>e7c8e6eb292ef515be8d56030897f123</gtr:id><gtr:otherNames>D?tsch V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1943-0264</gtr:issn><gtr:outcomeId>bGbbp6kaQNB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>08BC64A6-921D-4A4C-966A-AEB21EC95DB9</gtr:id><gtr:title>OTX2 regulates the expression of TAp63 leading to macular and cochlear neuroepithelium development.</gtr:title><gtr:parentPublicationTitle>Aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3081b0b8581f7e474fc4d6d4974c35a6"><gtr:id>3081b0b8581f7e474fc4d6d4974c35a6</gtr:id><gtr:otherNames>Palombo R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1945-4589</gtr:issn><gtr:outcomeId>56cb40e1a3bfc9.10615335</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9D5B67EC-F8FA-4B4A-BF8A-74DC87904BA6</gtr:id><gtr:title>Mutant IDH1 Downregulates ATM and Alters DNA Repair and Sensitivity to DNA Damage Independent of TET2.</gtr:title><gtr:parentPublicationTitle>Cancer cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/75863d44d38390b793a438ac87b9f44b"><gtr:id>75863d44d38390b793a438ac87b9f44b</gtr:id><gtr:otherNames>Inoue S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1535-6108</gtr:issn><gtr:outcomeId>58c6cdfec5c531.06849762</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4910DCB1-3F78-4CD4-BAAA-7F33C60E5C9D</gtr:id><gtr:title>miR-16 and miR-26a target checkpoint kinases Wee1 and Chk1 in response to p53 activation by genotoxic stress.</gtr:title><gtr:parentPublicationTitle>Cell death &amp; disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/867bb8a30b5c8f47afb401aa4b34c62f"><gtr:id>867bb8a30b5c8f47afb401aa4b34c62f</gtr:id><gtr:otherNames>Lezina L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>545fa7405927e1.18457233</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A4DDE30-7745-4244-84A1-0A2FD5B7E0A1</gtr:id><gtr:title>Connexin 26 (GJB2) mutations as a cause of the KID syndrome with hearing loss.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/06b1423b928b03697c3b3a2bf7ba1027"><gtr:id>06b1423b928b03697c3b3a2bf7ba1027</gtr:id><gtr:otherNames>Terrinoni A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn><gtr:outcomeId>gh1LVcmWiEK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F3AF510C-618F-4774-ADA7-C197F93EF607</gtr:id><gtr:title>MEKK1 binds HECT E3 ligase Itch by its amino-terminal RING motif to regulate Th2 cytokine gene expression.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5872a7f8cea7fdd5ebba4af7069546b"><gtr:id>e5872a7f8cea7fdd5ebba4af7069546b</gtr:id><gtr:otherNames>Enzler T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>F06A48AE6D8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CBDA8C67-1E32-4FB7-8AAD-83394A25B29E</gtr:id><gtr:title>Cleavage of the transactivation-inhibitory domain of p63 by caspases enhances apoptosis.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/965d8feba4031afcf8a01b411c83a7a0"><gtr:id>965d8feba4031afcf8a01b411c83a7a0</gtr:id><gtr:otherNames>Sayan BS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>0CC1CB47BEF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D0484E1-C3CF-4678-A8A6-DBFE81F44D00</gtr:id><gtr:title>NRF2 and p53: Januses in cancer?</gtr:title><gtr:parentPublicationTitle>Oncotarget</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/15f15e5a26ebf9d19327bfe518516dd0"><gtr:id>15f15e5a26ebf9d19327bfe518516dd0</gtr:id><gtr:otherNames>Rotblat B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1949-2553</gtr:issn><gtr:outcomeId>pm_12587_27_23174755</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B1A6157-F5F2-48D5-AF3A-B8D1DD7E1435</gtr:id><gtr:title>Serine and glycine metabolism in cancer.</gtr:title><gtr:parentPublicationTitle>Trends in biochemical sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8202ec23ce7877b2a6c8080563ce1fe"><gtr:id>f8202ec23ce7877b2a6c8080563ce1fe</gtr:id><gtr:otherNames>Amelio I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0968-0004</gtr:issn><gtr:outcomeId>545fa6f2c6cf14.22838871</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4E385713-6FAC-4AF4-90AF-8023106B8157</gtr:id><gtr:title>The ubiquitin proteasome system and its involvement in cell death pathways.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7876abe36dc197edd850bcd158433472"><gtr:id>7876abe36dc197edd850bcd158433472</gtr:id><gtr:otherNames>Bernassola F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>1D0293C3BE2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>01D9A101-7456-4D5D-BD50-1BA9A40762DF</gtr:id><gtr:title>Generation of DeltaTAp73 proteins by translation from a putative internal ribosome entry site.</gtr:title><gtr:parentPublicationTitle>Annals of the New York Academy of Sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/532598b98b028a69feb3aaf7c4089099"><gtr:id>532598b98b028a69feb3aaf7c4089099</gtr:id><gtr:otherNames>Sayan AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0077-8923</gtr:issn><gtr:outcomeId>A04E495A0A2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F656D5D2-949E-44C8-9972-F80D98B809D6</gtr:id><gtr:title>Differential altered stability and transcriptional activity of ?Np63 mutants in distinct ectodermal dysplasias.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6298163fd3bab036c6ebe08188743fbf"><gtr:id>6298163fd3bab036c6ebe08188743fbf</gtr:id><gtr:otherNames>Browne G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>RGU2eTEYu19</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CCD70927-0FE1-4A4A-A936-423B5BEADAE8</gtr:id><gtr:title>Depletion of the receptor for advanced glycation end products (RAGE) sensitizes towards apoptosis via p53 and p73 posttranslational regulation.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5099493fa5a6eeda8f94015fcebd6f2d"><gtr:id>5099493fa5a6eeda8f94015fcebd6f2d</gtr:id><gtr:otherNames>Brune M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>pm_12587_27_22543586</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E47624BA-F398-4F98-A842-8B12D4932448</gtr:id><gtr:title>The p53 family and the hypoxia-inducible factors (HIFs): determinants of cancer progression.</gtr:title><gtr:parentPublicationTitle>Trends in biochemical sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8202ec23ce7877b2a6c8080563ce1fe"><gtr:id>f8202ec23ce7877b2a6c8080563ce1fe</gtr:id><gtr:otherNames>Amelio I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0968-0004</gtr:issn><gtr:outcomeId>56cb40e5aa0454.91528471</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E20858B5-2FED-4D55-8203-9327834FE876</gtr:id><gtr:title>Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/712d7812d3373b2191d536d803f1ba68"><gtr:id>712d7812d3373b2191d536d803f1ba68</gtr:id><gtr:otherNames>Kroemer G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>B554F7E8E7C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FEBC6F0C-8731-4B30-B430-1151567A900D</gtr:id><gtr:title>Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).</gtr:title><gtr:parentPublicationTitle>Autophagy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3338e204a3c58e1fab88cb3342a71645"><gtr:id>3338e204a3c58e1fab88cb3342a71645</gtr:id><gtr:otherNames>Klionsky DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1554-8627</gtr:issn><gtr:outcomeId>58c6ced3a46008.40594184</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>04052110-14FD-4F7A-930D-58EF11F27990</gtr:id><gtr:title>Arterial ageing: from endothelial dysfunction to vascular calcification.</gtr:title><gtr:parentPublicationTitle>Journal of internal medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dcabdec3b5ebeb35f64f4a6aa72698e2"><gtr:id>dcabdec3b5ebeb35f64f4a6aa72698e2</gtr:id><gtr:otherNames>Tesauro M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0954-6820</gtr:issn><gtr:outcomeId>5aaa670f63e133.38168032</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FFC1327F-A20F-4B24-821D-CC7945221045</gtr:id><gtr:title>NF-kappaB inhibits T-cell activation-induced, p73-dependent cell death by induction of MDM2.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40de89ef302e7b6893e212bf5d961e6a"><gtr:id>40de89ef302e7b6893e212bf5d961e6a</gtr:id><gtr:otherNames>Busuttil V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>bAsnqKh3NG1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C95A103E-A733-47A8-9472-07D2ED4559CE</gtr:id><gtr:title>DNA damage-induced ubiquitylation of proteasome controls its proteolytic activity.</gtr:title><gtr:parentPublicationTitle>Oncotarget</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/12afaf6d03e6fd9da2b37068b0b886fb"><gtr:id>12afaf6d03e6fd9da2b37068b0b886fb</gtr:id><gtr:otherNames>Moiseeva TN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1949-2553</gtr:issn><gtr:outcomeId>pm_12587_27_23907514</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7706CBBF-492B-4F04-901C-4FE1715B5798</gtr:id><gtr:title>On Rita Levi-Montalcini.</gtr:title><gtr:parentPublicationTitle>Molecular neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/15a25fc8d85639e9e4f6c3b56a2a6100"><gtr:id>15a25fc8d85639e9e4f6c3b56a2a6100</gtr:id><gtr:otherNames>Melino G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0893-7648</gtr:issn><gtr:outcomeId>pm_12587_27_23389287</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1A62123B-A0F2-4840-B764-45591653D7FF</gtr:id><gtr:title>The mammary gland and the homeobox gene Otx1.</gtr:title><gtr:parentPublicationTitle>The breast journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/521ce7cc2f8ba60f7a4c1d5c5edaaebc"><gtr:id>521ce7cc2f8ba60f7a4c1d5c5edaaebc</gtr:id><gtr:otherNames>Pagani IS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1075-122X</gtr:issn><gtr:outcomeId>H8krP5v84KT</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>223B71B3-B712-41A0-9F57-F82D1F36CD6E</gtr:id><gtr:title>Respiratory distress and perinatal lethality in Nedd4-2-deficient mice.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/171449f92ea3c91ce20fe0598dcd48fe"><gtr:id>171449f92ea3c91ce20fe0598dcd48fe</gtr:id><gtr:otherNames>Boase NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>byEN78GiFnY</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB4E1899-1E0B-4294-8EA9-1F1E2F169447</gtr:id><gtr:title>Missense mutations in the TGM2 gene encoding transglutaminase 2 are found in patients with early-onset type 2 diabetes. Mutation in brief no. 982. Online.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7071d4ef4ce87dd1749a7a8fd92c18ab"><gtr:id>7071d4ef4ce87dd1749a7a8fd92c18ab</gtr:id><gtr:otherNames>Porzio O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>FF415D21DAF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B7E2E8AE-57A9-49CA-84D0-6771E6B1D730</gtr:id><gtr:title>MicroRNA-152 and -181a participate in human dermal fibroblasts senescence acting on cell adhesion and remodeling of the extra-cellular matrix.</gtr:title><gtr:parentPublicationTitle>Aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d4dfbc5f3f72a159e19a1e181ef4e64c"><gtr:id>d4dfbc5f3f72a159e19a1e181ef4e64c</gtr:id><gtr:otherNames>Mancini M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1945-4589</gtr:issn><gtr:outcomeId>pm_12587_27_23238588</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>64C1C6EC-C039-4515-B5EA-F6E9AF2D8A98</gtr:id><gtr:title>Embryonic stem cells and inducible pluripotent stem cells: two faces of the same coin?</gtr:title><gtr:parentPublicationTitle>Aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4ab3b5842b48569fa05b4782e9a089f3"><gtr:id>4ab3b5842b48569fa05b4782e9a089f3</gtr:id><gtr:otherNames>Romeo F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1945-4589</gtr:issn><gtr:outcomeId>pm_12587_27_23248145</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>590EC6B1-F79F-4942-8FA9-5B7968CAE286</gtr:id><gtr:title>TAp63 and DeltaNp63 in cancer and epidermal development.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf02bfffc596a84b2aa376016aa486ba"><gtr:id>cf02bfffc596a84b2aa376016aa486ba</gtr:id><gtr:otherNames>Candi E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>3FD9F181FA5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3493D1BE-62FB-4D4E-9660-955253C0D8CC</gtr:id><gtr:title>p73 in Cancer.</gtr:title><gtr:parentPublicationTitle>Genes &amp; cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d22fc1f6855fc0c192fe4e566ef0a2bd"><gtr:id>d22fc1f6855fc0c192fe4e566ef0a2bd</gtr:id><gtr:otherNames>Rufini A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1947-6019</gtr:issn><gtr:outcomeId>TgRv5ivED1u</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>58D492AF-AE0E-430C-82A8-BD69969D9CBB</gtr:id><gtr:title>TAp73alpha induces tau phosphorylation in HEK293a cells via a transcription-dependent mechanism.</gtr:title><gtr:parentPublicationTitle>Neuroscience letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4215c217848c45eaa4c6f947d1263ba9"><gtr:id>4215c217848c45eaa4c6f947d1263ba9</gtr:id><gtr:otherNames>Hooper C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0304-3940</gtr:issn><gtr:outcomeId>5F0644495B3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A0689CD7-44FE-4F82-BD6A-E3365E8ACF2C</gtr:id><gtr:title>Anti-tumoral effect of desmethylclomipramine in lung cancer stem cells.</gtr:title><gtr:parentPublicationTitle>Oncotarget</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b84cef5ab4776b4fa1c823b470fe7fc"><gtr:id>7b84cef5ab4776b4fa1c823b470fe7fc</gtr:id><gtr:otherNames>Bongiorno-Borbone L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1949-2553</gtr:issn><gtr:outcomeId>56cb40e66733b3.85859395</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1609C225-4A3F-47A4-88AC-652464756199</gtr:id><gtr:title>?Np63a modulates histone methyl transferase SETDB1 to transcriptionally repress target genes in cancers.</gtr:title><gtr:parentPublicationTitle>Cell death discovery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0b80ca2434b105038ead2cf2c4de2ec6"><gtr:id>0b80ca2434b105038ead2cf2c4de2ec6</gtr:id><gtr:otherNames>Regina C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2058-7716</gtr:issn><gtr:outcomeId>58c6ced32c2c48.93154064</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B7593B66-010A-4B60-942E-D7DA78E4B2FA</gtr:id><gtr:title>Rita's 102!!</gtr:title><gtr:parentPublicationTitle>Molecular neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ffb086832078f4b60af34e7bde6a6c9e"><gtr:id>ffb086832078f4b60af34e7bde6a6c9e</gtr:id><gtr:otherNames>Levi-Montalcini R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0893-7648</gtr:issn><gtr:outcomeId>aamN57CrrKV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A9EBAD55-6344-4CDF-9ED2-9B701C837A9A</gtr:id><gtr:title>P73 and age-related diseases: is there any link with Parkinson Disease?</gtr:title><gtr:parentPublicationTitle>Aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf6dbcc7eab91ddd02d8dafa51460879"><gtr:id>bf6dbcc7eab91ddd02d8dafa51460879</gtr:id><gtr:otherNames>Grespi F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1945-4589</gtr:issn><gtr:outcomeId>pm_12587_27_23271007</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C7AE3E3-8B18-4826-8A3C-B42B6ED6E80B</gtr:id><gtr:title>The p53 family: guardians of maternal reproduction.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Molecular cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e1e5c9daa7f462a838c26533d62be2b"><gtr:id>1e1e5c9daa7f462a838c26533d62be2b</gtr:id><gtr:otherNames>Levine AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1471-0072</gtr:issn><gtr:outcomeId>p91V2sG8EKX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CB7C258B-25BD-4689-B1E9-605D6E66DA74</gtr:id><gtr:title>Cerebral cavernomas in a family with multiple cutaneous and uterine leiomyomas associated with a new mutation in the fumarate hydratase gene.</gtr:title><gtr:parentPublicationTitle>The Journal of investigative dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d3512bd7429fe901371cde33c4bb017"><gtr:id>4d3512bd7429fe901371cde33c4bb017</gtr:id><gtr:otherNames>Campione E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-202X</gtr:issn><gtr:outcomeId>E5D623EF9DD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>507AC498-0824-4381-A1DD-5B898184479D</gtr:id><gtr:title>Perspective on multi-target antiplatelet therapies: high content phenotypic screening as an unbiased source of novel polypharmacological strategies.</gtr:title><gtr:parentPublicationTitle>Mini reviews in medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f21b0e2068cc66ca298b73771eefe30"><gtr:id>1f21b0e2068cc66ca298b73771eefe30</gtr:id><gtr:otherNames>Landr? V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1389-5575</gtr:issn><gtr:outcomeId>56cb40e9182fc3.89423804</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>989D0621-FBD0-43E5-A977-4543AD7C5980</gtr:id><gtr:title>Transglutaminases expression in human supraspinatus tendon ruptures and in mouse tendons.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a5d524fdf1ebf1a9d195b758c13510a2"><gtr:id>a5d524fdf1ebf1a9d195b758c13510a2</gtr:id><gtr:otherNames>Oliva F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn><gtr:outcomeId>0F5D491620B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1F7B2BAD-9394-4B6F-8F36-AB25D83189B6</gtr:id><gtr:title>Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f446e86d6836d8e6a5da49dfe563b87"><gtr:id>8f446e86d6836d8e6a5da49dfe563b87</gtr:id><gtr:otherNames>Galluzzi L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>5aaa66641a58c3.72347900</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BFF8B4A0-1C8E-41B7-962E-14E512487F3C</gtr:id><gtr:title>Scientists contemplate unexplained death in Austrian Alps.</gtr:title><gtr:parentPublicationTitle>EMBO molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c01529da9ea90bd6006ce2e14916afe8"><gtr:id>c01529da9ea90bd6006ce2e14916afe8</gtr:id><gtr:otherNames>Miller C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1757-4676</gtr:issn><gtr:outcomeId>Ai8CXEJrXY9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>33277046-8923-40DC-9430-F068B1E1E521</gtr:id><gtr:title>Exploiting tumour addiction with a serine and glycine-free diet.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8202ec23ce7877b2a6c8080563ce1fe"><gtr:id>f8202ec23ce7877b2a6c8080563ce1fe</gtr:id><gtr:otherNames>Amelio I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>5aaa6666bd3d54.89243787</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F8E661DE-A799-482E-95A8-D7011BBA3319</gtr:id><gtr:title>PTPN12 promotes resistance to oxidative stress and supports tumorigenesis by regulating FOXO signaling.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f2b31b40a6d85bb40516fce2cdeda2d6"><gtr:id>f2b31b40a6d85bb40516fce2cdeda2d6</gtr:id><gtr:otherNames>Harris IS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>pm_12587_27_23435421</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U132670600</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>34</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>